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Abstract 
 
Presence of micropollutants in water is a global concern because of their ability to potentially 
cause adverse effects in organisms at concentrations as low as a few ng/L, particularly when 
present as a component of complex mixture. Most of the endocrine disrupting compounds (EDC) 
and pharmaceutical and personal care products (PPCP) are not removed well in traditional 
wastewater treatment processes and enter the environment and spread throughout the water 
ecosystem. Advance oxidation processes (AOPs) are a powerful technology for the treatment of 
water and wastewater contaminants. They are characterized by the production of highly reactive 
and non-selective hydroxyl radicals, and by mineralization of refractory pollutants. However, 
complete mineralization of organic contaminants is expensive, while partial mineralization may 
not produce desirable water quality both for ecosystem as well as for potable purposes.  All these 
technologies require an efficient and powerful set of tools and assays in order to quantify the 
biological compatibility of treated water contaminated with micropollutants. Bioassays, which 
are powerful tools, can be used to screen the estrogencity and the toxicity of a complex chemical 
mixture. In this work, a full factorial design was applied to investigate the antagonistic-
synergistic interactions of different concentrations and mixtures of the four compounds; 17-β 
estradiol (E2), sulfamethoxazole (SMX) and bisphenol A (BPA) and humic Acid (HA). The 
estrogenic activity was determined by using the yeast estrogencity screen (YES) assay, and the 
genotoxicity of the compounds and their intermediates was monitored by using the Ames test, 
before and after ozonation, UV/ O3 and UV/ H2O2 which are very effective oxidative treatments 
for the degradation of various organic micropollutants in water. SMX showed ~ 100% removal 
in all the AOPs, the slowest removal occurred for only ozonation whereas the combination of 
UV with ozone and hydrogen peroxide produced much faster degradation rate. While E2 showed 
much higher degradation in ozonation and combination of UV increased the rate only by 18%. 
BPA also showed good removal with ozonation, by the addition of H2O2, the rate was reduced by 
86% from that of UV/ozonation. Humic acid demonstrated the lowest degradation rate of all the 
compounds tested. The effect of the presence of humic acid on the degradation rate constant of 
pure compounds and mixtures varied depending on the micropollutants type and the mixture. 
TOC removal was reduced when HA was added to all solutions. 
iii 
 
Humic acid and sulfamethoxazole had a synergistic interaction with 17-β estradiol that led to 
increase the estrogencity of water by 2.7- 4.7 times. BPA is a weak xenoestrogen that was able to 
create an impact upon E2 which is a strong estrogen by increasing the estrogencity of E2 by 2.4 
times. Some mixtures showed an antagonistic interaction that resulted in dropping EEQ.  No 
mutagenicity was shown by using the Ames test for all mixtures.  
The work demonstrated that bioassays such as estrogencity and mutagenicity and total organic 
carbon (TOC) reduction can be used to determine the optimum AOP treatment without 
conducting detailed chemical analyses. 
 
 
 
 
 
 
 
Keywords: 17-β estradiol, Sulfamethoxazole, Bisphenol A, Humic Acid, Advanced 
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Chapter One 
1.1 Introduction  
There has been an increasing concern in recent years about the occurrence, fate, and adverse 
effects of the micropollutants in aquatic systems including natural water resources and drinking 
water due to their potential harmful effects on human health, aquatic organisms and subsequent 
effects on the ecology (Fent et al. 2006; Jjemba 2006). Due to fast development in technology, 
industrialization and population growth, numerous harmful organic compounds are found in 
aquatic systems. Emerging contaminants (EC) such as pharmaceuticals and personal care 
products (PPCP) and endocrine disruptor compounds (EDCs), including antibiotics,  fragrances, 
contraceptives, and many other personal care products at concentrations ranging from ng/L to 
µg/L are reported in Canada and elsewhere (Ternes et al. 1999; Cajthaml et al. 2009; Silva et al. 
2011; Wu et al. 2012). The continuous input of the low concentrations of micropollutants may 
lead to important long-term consequences in aquatic ecosystems (Daughton et al. 1999).  The 
endocrine disruptor compounds have recieved lately an increased attention in health care and 
water quality (Colborn et al. 1993), as they are able to mimic natural hormones in the endocrine 
system or interfere with the action of endogenous hormones by disrupting signal pathways as 
endocrine disrupters. For example, estrogens can stimulate the growth of human breast cancer 
cells (Soto et al., 1991).  
These compounds are introduced to the environment as complex mixtures via many ways, 
mainly through the discharge of wastewater effluents due to their poor removal in traditional 
wastewater treatment processes. Recent literature reports the effet of EDCs on feminisation of 
the male fish due to the presence of estrogenic compounds in the WWTP effluent (Khanal  et al., 
2006. There are  studies in Canada as well as in all over the world showing the presence of 
synthetic estrogen, 17α-ethinyl- estradiol (EE2), and the endogenous estrogens such as 17β-
estradiol (E2), estrone, and estriol in the secondary effluents (Lee and Peart 1998; Ternes et al. 
1999; Metcalfe et al. 2001). Sohoni and Sumpter (1998) indicated that BPA can leach from food 
can linings into the products and produce estrogenic activity. Since early nineties many reviews 
dealing with the elucidation and effect of pharmaceuticals and personal care products indicate 
them as toxic (Heberer, 2002; Petrovic et al., 2003; Larsen et al., 2004; Miège et al. 2009). 
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Hirsch et al. (1999); Kolpin et al. (2002); Martinez-Carballo et al. (2007). Tamtam et al. (2008) 
have reportd global occurrence of antibiotics in aqueous matrixes, including wastewater 
treatment plants (WWTPs), groundwater, surface water, and sediment. Especially, 
sulfamethoxazole which is a synthetic antibiotics that has been detected in ground-water, in 
effluents of WWTPs, and in rivers (Hirsch et al. 1999; Miège et al. 2009; Xu et al. 2011). In 
addition to all of these micropollutants, dissolved organic matter (DOM), a mixture of various 
organic compounds of humic substances can have a synergistic effect that can increase the 
estrogenic activity of other estrogenic compounds (Vigneault et al. 2000; Liu et al. 2012; Chen, 
et al., 2012) or antagonistic effect by decreasing the estrogenic activity (Muir et al. 1994; Qiao 
and Farrell 2002; Janošek et al. 2007). 
Furthermore, runoff from the agricultural fields treated with biosolids contaminated with EDC 
can pollute the ground and surface water. At present, extensive research is being conducted on 
improving the degradation of the micropollutants both in wastewater as well as in the discharged 
effluents.  In wastewater, research is being conducted mainly on the improvement of both 
aerobic and anaerobic biodegradation of the micropollutants whereas tertiary treatment methods 
such as various membrane processes including ultrafiltration, reverse osomosis, etc., adsorption, 
and advanced oxidation processes are being used for the removal of micropolluants in the 
effluents from wastewater (Esplugas et.al., 2007; Abdelmelek et al., 2011).  
Advanced oxidation processes involving hydroxyl radicals OH•, the most powerful oxidizing 
agent, are found to degrade recalcitrant organic compounds have the potential to remove trace 
concentrations of micropollutants in water. OH• radical reacts with electron-rich sites on organic 
compounds and initiates complex radical chain reactions in aqueous phase (Klavarioti et al. 
2009). In water treatment applications, AOPs can be used either alone or coupled with other 
biological or physiochemical processes.  AOPs in water treatment refers to a specific subset of 
processes that involve O3, H2O2, and/or UV light (Andreozzi et al. 1999; Eibes et al. 2011; 
Esplugas et al. 2007; Wu et al. 2012; Silva et al. 2012; Shemer et al. 2006). There are several 
studies about the application of AOPs to remove the endocrine disrupting chemicals and 
pharmaceuticals and personal care products in water and wastewater.  UV coupled with H2O2 
removed many micropollutants effectively (Chen et al. 2006; Staehelin & Hoigne 1982; Bolton 
et al. 2003; Chen et al. 2007; Irmak et al. 2005; Neamţu & Frimmel 2006; Rosenfeldt and 
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Linden, 2004). Esplugas et al. (2007) found that ozonation was the most studied processes with 
good removal of the target pollutants. In addition, the combination of UV with O3 is an effective 
oxidation method in advanced water treatment for its destruction ability of various organics in 
water (Andreozzi et al. 1999). 
Complete mineralization of organic contaminants is expensive, while partial mineralization may 
not produce desirable water quality. The residual presence and activity of intermediates are hard 
to assess due to their low concentrations and difficult chemical analysis. Bioassays such as 
AMES test and yeast estrogen screen (YES) assay which are powerful tools can be used (Rizzo, 
2011) to screen the estrogencity and the toxicity of a complex chemical mixture as these 
compounds are never present as single compounds in ecosystems. Substantial theoretical 
challenges exist to assess the effect of exposures to xenobiotics, the synergisms, antagonist or 
additive responses of the individual mixture components (Silva et al., 2002).  Rajapakse et al. 
(2001) have shown that the weak xenoestrogens are able to create an impact upon strong 
estrogens. Chen et al. (2007) reported that the estrogenic activity was additive. 17-β estradiol 
(E2) and 17 ethinylestradiol (EE2) are the primary compounds driving estrogenic activity and 
that the concentrations of 4-nonylphenol (NP) and bisphenol A (BPA) used in the study had a 
negligible effect on estrogenic activity. Although, the importance of bioassays to determine the 
whole effluent toxicity after advanced oxidation is recognized in the scientific community, there 
is very limited information on the effect of dissolved organics (humic acids) on the intermediates 
and oxidation end products of various micropollutants.   
 
1.2 Objectives of the Present Study 
Base on the above, the objectives of the present study are: 
• Determine the performance of three advance oxidation processes, commonly used in 
water and wastewater treatment plants including O3, UV/O3 and UV/H2O2 on the 
degradation of the model organics namely sulfamethoxazole (antibiotic), 17-β estradiol 
(estrogenic), bisphenol A (xenoestrogen) in a kinetic study.  
• Evaluate the effect of different mixtures, concentrations and the presence of humic acid 
on the performance of different AOPs and the resultant water quality. 
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• Apply the bioassays to investigate the antagonistic-synergistic interactions of different 
concentrations and mixtures of the model compounds on the mutagenic and the 
estrogenic effects to determine possible health risks.  
 
1.3 Overview of Dissertation  
This thesis is divided into the following chapters:  
 Chapter 1 provides the background and the objectives of the research.  
 Chapter 2 presents a literature review of the present work and the theory behind it. 
 Chapter 3 describes the first stage of the research, in which the effects of three different 
advance oxidation treatments on different concentrations and mixtures of the model 
compounds were studied. 
 Chapter 4 discusses the results on the estrogenic activity determined by yeast estrogencity 
screen (YES) assay, and the genotoxicity monitored by using the Ames test, before and 
after different AOPs.  
 Chapter 5 reports the conclusions and followed by recommendations for future work.  
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Chapter Two 
Literature review 
2.1 Organic Micropollutants  
A wide variety of synthetic and natural organic micropollutants is present in the aquatic 
environment. They are found at trace concentrations (μg- ng/L) and can cause adverse effects on 
human and ecosystem (Stangroom et al. 1998; Schwarzenbach, 2006; Murray, 2010). Usually, 
micropollutants are synthetic chemicals and an estimated 50,000- 100,000 are commercially 
available with increasing number every year (Worldwatch Institute, 2011). However, the 
environmental influence of all of these compounds and the toxicity are not yet well known 
(Schwarzenbach, et.al. 2003). There have been increasing concern as well as research interest 
about these compounds which is evident in the increasing number of publications on this subject 
over the last decade, as shown in Figure 2.1.  
 
 
Figure 2.1: Publications on Micropollutants in the last decade (Fatta-Kassinos and Meric, 2011) 
The pathways of emission and fate of organic micropollutants such as pharmaceutical residues, 
biocides, hormones and endocrine disruptive compounds are shown in Figure 2.2.  Since many 
of these compounds are highly hydrophobic, a major fraction is partitioned into the solids in 
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wastewater, while a small fraction is removed in activated sludge plant.  Finally, these 
compounds enter the environment through disposed effluent, sludge and biosolids.   
 
 
Figure 2.2: Exposure routes of micropollutants in the environment 
(http://www.arhp.org/publications-and-resources/contraception-journal/august-2011) 
2.1.1 Endocrine disruption compounds (EDCs):  
EDCs are natural or synthetic agents which affect the synthesis, transport, secretion, binding, 
elimination or action of natural hormones in the body that are responsible for the maintenance of 
homeostasis, reproduction, development and/or behavior' according to US Environmental 
Protection Agency (USEPA) (Snyde, 2003; Caliman & Gavrilescu 2009). EDCs interact 
indirectly with the endocrine systems that control the body's function leading to excessive 
amounts or suppression of hormones (Vogel &Vision, 2004) causing the following problems: 
1- Sexual underdevelopment. 
2- Infertility.  
3-  Attention deficit or hyperactivity.  
4- Birth defects.  
5- Altered or reduced sexual behavior.  
6- Increased incidents of certain cancers.  
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7- Altered thyroid or adrenal cortical function, etc  
 
EDCs are chemicals that have specific function in target receptors (Halling-Sorensen et al., 1998; 
Jones et al., 2005). However, they can cause adverse impacts to non-target receptors (Jones et al., 
2005; Jasim et al., 2006), that interfere with endocrine (or hormone system) in animals and 
humans.  
EDCs may have an agonistic effect, which means the hormone will act as mimic by binding to 
the receptor sites of the target cells and activating a response, and an antagonistic effect, which 
means the EDC will act as a hormone blocker and no response is produced as the chemical binds 
to the receptor and prevents natural hormones from interacting (Birklett, 2003), as shown in 
Figure 3. 
 
Figure 2.3: Endocrine disruption processes (Birklett, 2003) 
 
2.1.2 Pharmaceutical and personal care products (PPCPs):   
PPCPs are a group of compounds which include pharmaceutical drugs, ingredients in cosmetics, 
food supplements and other personal care products, as well as their respective metabolites and 
transformation products. PPCPs are continuously introduced into the environment and are 
prevalent at small concentrations, which can affect water quality and potentially impact drinking 
water supplies, ecosystem and human health. Some of the PPCPs that have been reported in the 
aquatic environment are analgesics and anti-inﬂammatory drugs, antibiotics/bacteriostatic 
(antibacterial drugs), antiepileptic drugs, oral contraceptives, antiseptics, musk fragrances, sun 
screen agents, and others. Pharmaceuticals are biologically active compounds and are designed 
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to be resistant to biodegradation in order to improve their desired pharmacological action, for 
this reason they have an environmental persistence, which makes them difficult contaminants to 
deal with (Fatta-Kassinos and Meric, 2011). 
2.2 Model compounds 
2.2.1 17-β estradiol (E2): 
17-β estradiol is an important type of estrogenic compound; the physical characteristics are 
shown in Table 2.1. de Mes et al. (2005) & Jobling et al. (2006) mentioned that the main source 
of estrogens to the aquatic environment consist of the  natural and synthetic steroidal hormones 
of the human and animal excretion.  
Table 2.1: Physicochemical properties of 17-β estradiol (Silva et al. 2012) 
Characteristics 17-β estradiol 
Molecular formula C18H24O2 
Molecular structure 
 
Molecular weight (g/mol) 272.38 
Water solubility (mg/L) 3.6 
pKa 10.4 
log Kow 3.9-4.0 
Vapour pressure (mm Hg) 2.3   10 10 
Sorption constant, Koc 3300 
Henry’s Law constant (Pa m3/mol) 3.64  10 11 
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E1, E2 and E3 are natural estrogens that are derived from cholesterol occur in human; they are 
important for the health of the reproductive tissue, skin, breast and brain (Silva et al. 2012). 
Average daily excretion rate of these three natural hormones is given in Table 2.2 (Johnson et al. 
2000). EE2 is synthetic estrogen which is present in the contraceptive pill; it is also a major 
contributor to the total estrogencity of sewage effluent (Cargouet et al., 2004; Kidd et al., 2007). 
Table 2.2: Estimation of estrogen excretion by humans (per person) in µg/day (Johnson et al. 
2000) 
 
The estrogens get deconjugated by fecal flora to form estrogenically active free form (Dray et al., 
1972). Due to their relatively hydrophobic property, hormones are likely to be eliminated by 
sorption onto the solids (Lia et al., 2000; Yu and Huang, 2005), and this is a major challenge to 
extract the target compound from the sewage samples. Hernandez-Raquet and Combalbert( 
2010) proposed a degradation pathway of estrogens by bacteria as shown in Figure 2.4.    
                       
Figure 2.4: The degradation pathway of estrogens by bacteria under aerobic (solid line), anoxic 
or anaerobic conditions (dashed line), and by algae (dotted line). (a) Lee and Liu 2002, (b) 
Czajka and Londry 2006, (c) Ke et al. 2007, (d) Jarvenpaa et al. 1980, (e) Lai et al. 2002). 
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2.2.2 Sulfamethoxazole (SMX):                                 
Sulfonamide is an antibiotic that is widely used in human therapy and livestock production. The 
physical characteristics are shown in Table 2.3. Recently there has been a concern about the 
antibiotics residue in the environment and their effects to various organisms as shown in Figure 
2.5. Bacteria isolated from sewage bioreactors and the wastewater effluent has been shown to 
exhibit resistance to some antibiotics (Gulkowskaa, 2008; Shinwoo Yang, 2003).  It functions by 
competitively inhibiting (i.e., by acting as a substrate analogue) enzymatic reactions involving 
para- aminobenzoic acid (PABA). PABA is needed in enzymatic reactions that produce folic 
acid, which acts as a coenzyme in the synthesis of purine, pyrimidine and other amino acids. 
Sulfonamide is also present in other medications that are not antimicrobials, and is also used in 
the treatment of inflammatory bowel diseases, skin and soft tissue infections or urinary tract 
infection of pets by bacteria (e.g., sulfadiazine, sulfamethazine etc.). 
 
Table 2.3: Physicochemical properties of Sulfamethoxazole 
Characteristics Sulfamethoxazole 
Molecular formula 
 
C10H11N3O3S 
 
Molecular structure 
 
Molecular weight (g/mol) 
 
253.279 
 
Water solubility (mg/L) 
 
610 
 
pKa 
 
5.6-6.0 
 
log Kow 
0.5-0.9 
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 In this study we will focus on sulfamethoxazole (SMX), which is one of the sulfanilamide 
compounds, that has been detected in surface water and wastewater (Larcher and Yargeau, 
2012). Brown et al. (2006) found that sulfamethoxazole demonstrated poor removal (20%) in 
biological treatment process, and it forms several intermediates as shown in Table 2. Miao et al. 
(2004) and Xu et al. (2007) also indicated that sulfonamides could withstand different treatment 
processes in the WWTPs, and also it causes antibacterial resistance in biological wastewater 
treatment and the environment (Kümmerer, 2009; Reinthaler et al., 2003; Volkmann et al., 
2004). 
 
Figure 2.5: Veterinary antibiotics in the environment (Kemper 2008)  
 
2.2.3 Bisphenol A (BPA):  
 
Bisphenol A has been used extensively for the production of polycarbonates and epoxy resins 
over the past few decades (Metrzler, 2001). There is no clear consensus in the literature 
regarding the levels at which BPA can cause toxicity and the type of toxicity caused by it. 
Sohoni and Sumpter (1998) indicated that BPA can leach from food can linings into the products 
and produce estrogenic activity. Table 2.4 shows BPA properties, that it has solubility in water 
much greater than its EC50, and potentially toxic to the aquaticecosystem. Sajiki and Yonekubo 
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(2004) observed that BPA leached from polycarbonate tubes at 37C, suggesting that it can cause 
a problem when the temperature is elevated. There are other studies about the estrogenic potency 
and biodegradation of Bisphenol A (Lia et al., 2004). Figure 2.6 shows the biodegradation 
pathway of BPA (Ike et al., 2002). 
 
Table 2.4: Physicochemical properties of Bisphenol A 
 
Characteristics 
 
Bisphenol A 
Molecular formula C15H16O2 
Molecular structure 
 
Molecular weight (g/mol) 228.29 
Water solubility (mg/L) at 289 K 120  ppm (21.5 °C) 
pKa 9.6 
log Kow 3.32 
Melting point 330.4 K 
 
 
Figure 2.6: The biodegradation pathway of BPA (Ike et al., 2002) 
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2.2.4 Humic acid (HA): 
 
Humic acid is a complex mixture of variety of different acids with concentrations ranging from 
several mg/L to several tens of mg/L; it is one type of natural organic matter (NOM) that present 
in ground water, lakes, streams and other water bodies, HA is of biological origin of aquatic 
plants and animals (Burges et al. 1964) HA is one type of mixture of various organic compounds 
in the humic substances, which represent 80% of the total organic carbon of natural waters 
(Buftle et al. 1978), and it also includes fulvic acids (FA), and humins which is known as the  
 
Table 2.5: Physicochemical properties of humic acids 
 
Characteristics 
Humic acid 
Molecular formula Average chemical formula C187H186O89N9S1 
Molecular 
structure 
 
Molecular weight (g/mol) <1000 to >10,000
a
 
Water solubility (mg/L) 
more soluble in the aqueous phase 
b&c
, 
however with low pH leads to lower the 
solubility 
e 
pKa 
4.65
d 
log Kow 
<-2.8
e 
a. (Shuang et al. 2014) 
b. Lindstrom et al. 1988 
c. (Tipping 1981) 
d.  (Berthat & Choppin 1978) 
e. (Juckera & Clarkb 1994) 
 
 
19 
 
dissolved organic matter (DOM). Therefore, concentrations of humic acid are traditionally 
estimated as the concentrations of organic total organic carbon (TOC) or dissolved organic 
carbon (DOC). 
Humic macromolecules form negative charges bound due to the presence of the carboxylic and 
phenolic groups that cross-linked carbon network of HA when dissociate in aqueous media, 
which make it interact with various organic pollutants with positive-charged group (Shuang et al. 
2012). The phenolic and carboxylic groups, N-heterocyclic compounds, and lignin 
decomposition products in HA are preferred binding sites and responsible to site-specific 
sorption (Thiele-Bruhn et al. 2004). Therefore a serious environmental problem is caused by HA 
in water treatment due to the formation of disinfection by-products (DBPs) which affect the water 
quality as HA is present in the natural waters which leads to adsorption of other micropollutants 
to it (Shuang et al. 2014). Arnarson & Keil 2000 suggested six mechanisms to be involved in the 
adsorption of organic matter to mineral surfaces: ligand exchange, cation bridges, anion 
exchange, cation exchange, van der Waals interactions and hydrophobic effects. 
 
2.3 The presence of the model compounds in the different water matrixes in 
the environment 
 
In the aquatic environment, dissolved organic matter (DOM) found at concentrations of 0.5 to 50 
mg/L, they are the decomposition products of dead organic matter, and approximately 50–70% 
of it is humic substances (HS). Molot et al. (1992), found that the DOM concentration in lakes of 
Ontario is 1.7mg/L to 5.2 mg/L and Bertilsson & Tranvik (2000) recorded 2- 22 mg/L in Ontario 
lakes. Bisphenol A concentration in activated sludge system effluent in Canada is 330- 680 ng/L 
(Melcer, H. and Klecˇka, G., 2011).  In wastewater treatment plants WWTP influent the 
concentration of BPA is 2025- 2376 ng/L (Claraa,  et al., 2005). Avila, et al.(2009) found that the 
influent for industrial effluent is 1920 to 11100 ng /L, for domestic is 2260 to 5370 ng /L and for 
mixed is 1320 to 7360 ng /L. The BPA concentration in groundwater is 70 to 1900 ng /L (Latorre 
et al., 2003). Sulfamethoxazole in wastewater treatment plants WWTP influent is in the range of 
390- 1000 ng/L (Brown, K.D., 2006), and in surface water it is n.d. (not detected) - 470 ng/L 
(Hirscha, R., et al., 1999), and 400- 2100 ng/L (Brown, K.D., 2006). 17β-Estradiol in surface 
water is 9 ng/L (Kolpin et al. 2002). Furthermore <LOD <0.3- 0.9 ng/L (Belfroida, et al., 1999) 
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and LOD  1 ng/L (Stumpf et al., 1996). E2 present in aquatic environment through wastewater 
discharges at minimum detectable level (MOL) to 3.7 ng/L, and the environmental 
concentrations is less than detection to greater than 140 ng/L (Snyder et al., 1999). E2 is in river 
water of Germany is <30 ng/l to a maximum of 70 ng/L (Wiegel, s., et al., 2004).While the 
concentration in the primary efﬂuent of WWTP is 2400 ng/L (Hartig C., et al., 1999). 
According to the studies above the ratio of the concentrations of the model compounds chosen in 
this study is the environmental values of waste water treatment plant efﬂuent is ~ 0.06: 1:  6.96: 
6000 for 17β-Estradiol (E2): Bisphenol A (BPA): Sulfamethoxazole (SMX): Humic acid (HA) 
in the respectively as shown in Table 2.6.  
Table 2.6: The concentration and the ratio of Bisphenol A, 17β-Estradiol, Sulfamethoxazole and 
Humic acid (HA) in waste water treatment plants WWTP efﬂuent 
Waste water treatment plants WWTP efﬂuent 
Bisphenol A  (BPA) 17β-Estradiol  (E2) 
Sulfamethoxazole 
(SMX) 
Humic acid (HA) 
26- 76 ng/L  
[Claraa, M., etal., 2005] 
0.9 ng/L 
[Belfroida, A.C., et al., 
1999] 
400 ng/L 
[Hirscha, R., et al., 
1999] 
1.75- 5 mg/L 
[Molot, L.A., et al., 
1992] 
 2- 10 ng/L 
[Stumpf et al., 1996] 
310 ng/L 
[Brown, K.D., 2006] 
1.8- 4.8 mg/L (Hudson 
et al. 2003) 
 Rarely detected 
[Kima , et al., 2007] 
rarely detected 
[Kima , et al., 2007] 
 
 showed 
very rare detection and 
low concentration 
 
[Ternes et al., 1999a, b; 
Baronti et al., 2000; 
Huang and Sedlak, 
2001; Kolpin et al., 
2002] 
 
 
 
Average Average Average Average 
51 ng/L 3.45 ng/L 355 ng/L 300,0000ng/L 
 
 
2.4 Synergy 
This is a common phenomenon in aquatic biotests where the interaction of biological active 
agent produces a stronger effect than the additive calculation (Berendaum 1989). In a study 
where a mixture of 13 pharmaceuticals resulted in a 10–30% reduction in the growth of human 
 
 
21 
 
embryonic kidney cells after 2 days of exposure in vitro, while no effects were observed when 
the chemicals were present individually (Rice and Mitra, 2007; Carballa and Lema, 2006) 
showing the effect of background water quality on the effect of individual EDCs. In addition the 
weak xenoestrogens are able to create an impact upon strong estrogens (Rajapakse, et al., 2001),  
 
Table 2.7: A comparison study from different references about the synergistic, additive 
or antagonistic effect when found in a mixture 
Molar ratio 
E2: BPA 
Notes 
Presence of 
other 
compounds in 
the mixture 
Effect on the estrogencity Reference 
1: 20000  ------ The absorbed response were 
considerably higher  than those 
of the hormone alone 
Rajapakse, et 
al., 2001 
1:5000  ------ Indistinguishable from E2 
alone  
Rajapakseet al., 
2001 
1: 25000 of 11 
xenoestrogens 
including 
BPA –  
1: 100000 
These 
xenoestrogens are 
at levels below 
individual 
absorbed effect 
(NOEC)  
Another 10 
xenoestrogens 
Dramatic enhancement of 
mixture response, more than 
doubling the effect of E2 
alone 
Rajapakse,  et 
al., 2002 
Estradiol was 
used as 
reference 
compound 
These 
xenoestrogens are 
at levels below 
individual 
absorbed effect 
(NOEC) 
8 
xenoestrogens 
mixed together 
xenoestrogens are able to act 
together when combined at 
concentrations below their 
NOECs to produce significant 
effects 16 times increase in 
the estrogencity  
Silva, , et al, 
2002 
1: 60 EE2 has high 
estrogenic 
potency of the 
steroids. EE2 was 
approximately 11 
to 27 times more 
potent than E2 in 
fish ( Thorpe, 
K.L.,et al., 2003) 
EE2 and NP, 
the ratio for 
E2: EE2: 
BPA: NP is 
1:5: 60:200 
The estrogenic activity was 
additive. E2 and EE2 are the 
primary compounds 
driving estrogenic activity and 
that the concentrations of 
NP and BPA used in this study 
have a negligible effect on 
estrogenic activity. 
Chen, P. J.,et 
al., 2007 
E2: EE2 
(25:1) 
  E2 and EE2 are each able to 
contribute to the overall effect 
of the mixture, producing 
a mixture that is more potent 
than either of the individual 
chemicals 
Thorpe, K.L.,et 
al., 2003 
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and the bioavailability of E2 was increased by low concentrations of humic acid (Chen et al. 
2012), bioconcentration (Chen et al. 2012), furthermore changing the permeability of biological 
membranes (Vigneault et al. 2000). Table 2.7 shows the synergistic, additive or antagonistic 
effect when found in a mixture. 
 
2.5 Removal of micropollutants in wastewater treatment plants (WWTPs) by 
advance oxidation processes (AOPs) 
The quality of the treated effluent in WWTPs is measured by the removal of nitrogen and 
phosphate, pathogens, suspended solids, metals, and organic load. The micropollutants are 
poorly removed in conventional WWTP using physical and biological processes. In order to 
remove them, tertiary or advanced treatment step e.g. ultrafiltration, flocculation, ozonation, 
advanced oxidation, or reverse osmosis is needed, which is seldom used in standard WWTPs 
because of their high cost. However, recently many treatment plants are using UV-based 
disinfection processes for tertiary treatment. UV-oxidation is one of the advanced oxidation 
processes, which are good engineering solutions to eliminate the residual micropollutants and 
their metabolites derived from biological systems (Fatta-Kassinos and Meric 2011).  
 
 
 
Figure 2.7: Scheme showing the principle species in the decomposition of ozone in pure water 
initiated by hydroxide ions  (Glaze et al. 1987) 
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Advanced oxidation processes refer specifically to processes in which oxidation of organic 
contaminants occurs primarily through reactions with hydroxyl radicals. In water treatment 
applications, AOPs usually refer to a specific subset of processes that involve O3 as shown in 
Figure 2.7, H2O2, and/or UV light (Kommineni etal., 2008) Figure 2.8. There are several studies 
about the application of AOPs to remove the endocrine disrupting chemicals and 
pharmaceuticals and personal care products in water and wastewater. Table 2.8 shows different 
AOPs for Bisphenol A, 17β-Estradiol, sulfamethoxazole. 
 
 
 
Figure 2.8: Schematic diagram of the element of mass and photon transfer, and chemical 
processes involved in the UV/O3 process (Glaze et al. 1987) 
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Table 2.8: Different AOPs for Bisphenol A, 17β-Estradiol and Sulfamethoxazole 
   Bisphenol A  
Water 
Matrix type 
PH AOPs Type  Concentrat
ion used 
Results Reference 
Milli-Q 
deionized 
water 
5.3 - 4.3 
UV and 
UV/ 10 ppm 
H2O2 
 
13.7 ppm 
UV alone did not effectively 
degrade BPA, were as UV/ 
AOP with adequate H2O2 and UV 
influence were highly effective 
for removing aqueous estrogenic 
activity to below detectable levels. 
Chen et al. 
2006 
pure water 
surface water 
and 
wastewater 
effluents 
 
UV/ and 25.5 
ppmH2O2 
 
118.7ppm 
Presence of hydrogen peroxide. 
17ppm H2O2 gave around 60% 
removal better results of 
degradation 45% removal after 90 
min using 8.5 ppm 
Neamtu 2006 
aqueous 
samples 
Adjusted 
to 7.0 
 
10 mg 
/L of inﬂuent oz
one gas 
11.641ppm 
Parent compound and complete min
eralization of BPA may need 
extended ozonation. 
Garoma 2010 
 
Milli-Q 
deionized 
water 
 
O3, UV- H2O2 
and UV-TiO2 
11.643 
ppm 
The incomplete removal of TOC. 
BPA conversion was similar for all 
the experiments. 2 hours of 
treatment to reduce the TOC by 
41% for O3 and UV/ H2O2 
Gilmour, 2012 
 
aqueous 
medium 
5.25±0.0
3 
Ozone and 
Ozone/UV 
5.7- 91.3 
mg/L 
There was no significant difference 
in O3 amount consumed for 
complete conversion of BPA by 
O3 and O3/UV systems.  
Irmak et al., 
2005 
17-β stradiol (E2) 
Wastewater 
samples 
 Ozonation  80% removal Nakada 2007 
aqueous 
medium 
6.25±0.0
5 
Ozone and 
Ozone/UV 
5.4- 108 
mg/L 
UV decreased the O3 consumption 
by 22.5% in converting the same 
amount of E2 
Irmak et al. 
2005 
Ultrapure 
water 
buffered 
to 8.10 
ozone 
E2 was 
used to 
compared 
with their 
model 
compound 
80% removal 
Broseus et al. 
2009 
distilled water 7.5 
Oxidation 
chlorination and 
ozonation 
0.027 ppm 
 
Both chlorination and ozonation 
removed from 75% to 99% and  
resulted in a similar estrogencity 
trend 
Alum et al. 
2004 
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Continue Table 2.8 
Sulfamethoxazole (SMX) 
MQ and 
secondary 
treated 
wastewater 
4.1 
 
O3 (O3/UV) 
 
10 ppm 
After 7- 10 min Bellow detection 
limit. 10- 20 % TOC removal after 
1 hr for O3 
25- 35 % TOC removal UV- O3 
Beltran et al., 
2008 and 
Beltran et al. 
2012 
 
different 
PH 
Ozonation 200 ppm 
After 15 min of Ozonation the 
complete antibiotic abatement was 
almost achieved; after 15 min of 
Ozonation just 10% of 
mineralization. 
Dantas et al. 
2008 
activated 
sludge 
 
 
sand filtration 
and Ozonation 
 
Ozonation removed 80% or 
more of the, Sulfonamide 
Nakada et al. 
2007 
the input and 
output of the 
secondary 
clarifier of 
Sewage 
Treatment 
Plant (STP) 
 Ozonation  
Ozonation with doses lower than 90 
mM allowed the removal of 
Sulfamethoxazole which  
exhibited removal efficiencies 
below 20% in the STP treatment. 
Rosal et al. 
2010 
 
River water, 
received at the 
pilot plant had 
been 
prechlorinated  
 
 
photo catalytic 
reactor  
UV/TiO2 
5 mg of 
each 
compound 
as 
transferred 
to 3000 
mgallon DI 
water. 
Concentrations of all compounds 
Decreased following treatment. No 
estrogenically active transformation 
products were formed during 
treatment 
Benotti et al. 
2009 
wastewater 
treatment 
plant effluent 
6.6-7.1 
Ozonation 
followed by 
biological 
activated carbon 
filtration 
 
The non-specific toxicity of the by-
products mixture was 30-40% 
lower than the parent compounds. 
Increasing the ozone dose further 
will not necessarily lead to 
substantive gain in water quality. 
 
Reungoat et 
al. 2012 
 
2.6 Bioassays  
The bioassays which are powerful tools can be used to screen the estrogencity and the toxicity of 
a complex chemical mixture.  It measures the response of organisms exposed to contaminants in 
comparison with a control. They have been used to establish the toxicity levels of target 
contaminants, genotoxicity of micropollutants and their degradation products and intermediates 
in aqueous matrices for aquatic organisms (Rizzo, 2011).  
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2.6.1. The yeast estrogen screen (YES assay):   
Estrogenic activity is determined using the YES assay as described by Routledge and Sumpter 
(1996). This assay is based on a DNA recombinant strain of the yeast Saccharomyces cerevisiae, 
which contains a gene for the human estrogen receptor hER and expression plasmids carrying the 
reporter gene lac-Z encoding the enzyme β-galactosidase. Estrogenic active ligands induce the 
expression of the lac-Z gene followed by the synthesis of the enzyme β-galactosidase. This 
enzyme releases chlorophenol red from the chromogenic substrate chlorophenol red-β-d-
galactopyranoside (CPRG) as shown in Figure 2.9. The absorbance resulting from the color 
change from yellow to red is a direct measure for the estrogenic activity of the test compound. 
 
Figure 2.9: Schematic of the estrogen- inducible expression system in yeast (Tamaoto et. al., 
2001) 
2.6.2 The Ames test:  
 
The Ames test is used to detect the genotoxicity of the compounds such as typical genotoxins 
like aromatic amines that can cause mutation (Guidance for Industry, 2012), which can be 
defined as deleterious action on a cell's genetic material.  Genotoxicity means damage to the 
genetic material of the cell compounds including genetic damage to DNA, fixation of damage to 
DNA, and mutation by various mechanisms. Several studies have been conducted to determine 
the effect of the micropollutant on the genotoxcity in water and wastewater (Crebelli et. al., 
1995).       
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The mutagenic activity was determined by using the Ames test (Ames et al., 1975) using 
Salmonella typhimurium strains, carrying mutation(s) in the operon coding for histidine 
biosynthesis. The assay is based on a bacterial reverse mutations occurring in histidine-
deficiency mutants as shown in Figure 2.10, of five strains of Salmonella typhimurium strains 
(TA 97, TA98, TA100, TA102, TA1535) and two strains of E.coli.  
Traditionally, reverse-mutation assays have been performed using agar plates, known as `pour 
plate', plate-incorporation' or `agar-overlay' assays. An alternate assay performed entirely in 
liquid culture is the `Fluctuation test', originally devised by Luria and Delbruck (1943) and was 
modified by Hubbard et al. (1984), and will be adopted in this work. The advantages of this test 
are the following:                                           
1- It is more sensitive than the plate-incorporation assay, because it allows testing for higher 
concentration of samples (up to 75%v/v). 
2- The concentration of bacteria remains constant during the auxotrophic growth phase. 
3- It is a low cost and shorter time. 
 
 
Figure 2.10: Salmonella typhimurium TA 100 carrying mutation (http://www.ebpi.ca) 
 
 
 
 
 
28 
 
 
2.7 References   
 
Alum, A., Yoon, Y., Westerhoff, P., Abbaszadegan, M. 2004. Oxidation of Bisphenol A, 17beta-
Estradiol, and 17alpha-Ethynyl Estradiol and Byproduct Estrogenicity. Environmental 
Toxicology 19, 257–264. 
Ames, B. N., McCann, J., Yamasaki, E. 1975. Methods for detecting carcinogens and mutagens 
with the Salmonella/mammalian-microsome mutagenicity test. Mutation Research 31, 347–
364. 
Avila, J. S., Bonet, J., Velasco, G., Lacorte, S. 2009.  Determination and occurrence of 
phthalates, alkylphenols, bisphenol A, PBDEs, PCBs and PAHs in an industrial sewage 
grid discharging to a Municipal Wastewater Treatment Plant. Science of the Total 
Environment 407, 4157–4167. 
Baronti, C., Curini, R., D’Ascenzo, G., Di Corcia, A., Gentili, A., Samperi, R. 2000. Monitoring 
natural and synthetic estrogens at activated sludge sewage treatment plants and in a 
receiving river water. Environ. Sci. Technol. 34, 5059–5066. 
Belfroida, A. C., Horsta A. V., Vethaakb A. D., Schafer, A. J. Rijsc, G. B. J., Wegenera, J., 
Coﬁnoa, W. P. 1999. Analysis and occurrence of estrogenic hormones and their 
glucuronides in surface water and waste ater in The Netherlands. The Science of the Total 
Environment 225, 101–108.  
Beltra´n., F. J., Aguinaco, A., Garcı´a-Araya, J. F., Oropesa, A. 2008. Ozone and photocatalytic 
processes to remove the antibiotic sulfamethoxazole from water. Water research. 42, 3799–
3808. 
Beltrán, F. A., Aguinaco, A., García-Araya, J. F. 2012. Application of Ozone Involving 
Advanced Oxidation Processes to Remove Some Pharmaceutical Compounds from Urban 
Wastewaters. Ozone: Science & Engineering 34, 3–15. 
 
 
29 
 
Benotti, M. J., Stanford, B. D., Wert, E. C., Snyder, S. A. 2009. Evaluation of a photocatalytic 
reactor membrane pilot system for the removal of pharmaceutical and endocrine disrupting 
compounds from water. Water research 43, 1513–1522.  
Berendaum, M.C. 1989. “What Is Synergy?”, Pharmacological Reviews 41, 93–141. 
Birklett, J. W. 2003. Scope of the problem. In Endocrine Disruptors in Wastewater and Sludge 
Treatment Processes. Lewis Publishers, Boca Raton, Florida. 
Birth Control Hormones In Water: Separating Myth From Fact. 
<http://www.arhp.org/publications-and-resources/contraception-journal/august-2011> 
Broséus, R., Vincent, S., Aboulfadl, K., Daneshvar, A., Sauvé, S., Barbeau, B., Prévost, M. 
2009. Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during 
drinking water treatment. Water Research 43 (18), 4707. 
Brown, K. D., Kulis, J., Thomson, B., Chapman, T. H., Mawhinney, D. B. 2006. Occurrence of 
antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio 
Grande in New Mexico. Science of the Total Environment 366, 772–783. 
Buftle, J., Deladoey, P., Haerdi, W. 1978. The use of ultra- filtration for the separation and 
fractionation of organic ligands in freshwaters, Anal. Chim. Acta 101, 339-357. 
Burges, N. A., Hurst, H. M., Walkden, B. 1964. The Phenolic Constituents of Humic Acid and 
Their Relation to the Lignin of the Plant Cover. Geochimica et Cosmochimica Acta 28 (10-
11), 1547–1552. 
Caliman, F. A., Gavrilescu, M. 2009. Pharmaceuticals, personal care products and endocrine 
disrupting agents in the environment e a review. Clean-Soil Air Water 37 , 277–303. 
Carballa, M., Omil, F., Alder, A. C., Lema, J. M. 2006. Comparison between the conventional 
anaerobic digestion of sewage sludge and its combination with a chemical or thermal pre-
treatment concerning the removal of pharmaceuticals and personal care products. Water 
Science & Technology  53 (8), 109–117. 
 
 
30 
 
Cargouet, M., Perdiz, D., Mouatassim-Souali, A., Tamisier- Karolak, S., Levi, Y. 2004. 
Assessment of river contamination by estrogenic compounds in Paris area (France). 
Science of the Total Environment 324, 55–66. 
Chen, L., Shen, C., Tang, X., Chen, C., Chen, Y. 2012.  Estrogenic effects of dissolved organic 
matter and its impact on the activity of 17β-estradiol. Environ Sci. Pollut. Res. 19, 522–
528. 
Chen, P. J., Rosenfeldt, E. J., Kullman, S. W., Hinton, D. E., Linden, K. G. 2007. Biological 
assessments of a mixture of endocrine disruptors at environmentally relevant 
concentrations in water following UV/H2O2 oxidation. Science of the Total Environment 
376, 18–26. 
Chen, P-J., Linden, K. G., Hinton, D. E., Kashiwada, S., Rosefeldt, E. J., Kullman, S. W. 2006. 
Biological assessment of bisphenol A degradation in water following direct photolysis and 
UV advanced oxidation. Chemosphere 65(7), 1094–1102. 
Claraa, M., Strenna, B., Gansb, O., Martinezb, E., Kreuzingera, N., Kroissa, H. 2005. Removal 
of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a 
membrane bioreactor and conventional wastewater treatment plants Water Research 39, 
4797–4807. 
Crebelli, R., Andreoli, C., Carere, A., Conti, L., Crochi, B., Cotta-Ramusino, M., Benigni, R. 
1995. Toxicology of halogenated aliphatic hydrocarbons: structural and molecular 
determinants for the disturbance of chromosome segregation and the induction of lipid 
peroxidation. Chem Biol Interact 98(2), 113–129. 
Czajka, C. P., Londry, K. L. 2006. Anaerobic biotransformation of estrogens. Sci Total Environ 
367, 932–941. 
Dantas, R. F., Contreras, S., Sans C., Esplugas, S. 2008. Sulfamethoxazole abatement by means 
of Ozonation. Journal of Hazardous Materials 150, 790–794. 
 
 
31 
 
De Mes, T., Zeeman, G., Lettinga, G. 2005. Occurrence and fate of estrone, 17b-estradiol and 
17a-ethynylestradiol in stps for domestic wastewater. Reviews in Environmental Science 
and Biotechnology 4 (4), 275. 
Dray, J., Dray, F., Tiller, F., Ulman, A. 1972. Hydrolysis of urine metabolites of different steroid 
hormones by β-glucuronidase of Escherichia coli. Ann Inst Pasteur 123, 853–857. 
Environmental bio-detection products inc. 2012. Salmonella typhimurium TA 100 carrying 
mutation. <http://www.ebpi.ca> 
Fatta-Kassinos, D., and Meric, S. 2011. Pharmaceutical residues in environmental waters and 
wastewater: current state of knowledge and future research. Anal Bioanal Chem 399, 251–
275. 
Garoma, T., Matsumoto, S. A., Wu, Y., Klinger, R. 2010. Removal of Bisphenol A and its 
Reaction-Intermediates from Aqueous Solution by Ozonation. Ozone: Science and 
Engineering, 32(5), 338–343. 
Glaze, W. H., Kang, J-W.,  Cjapin, D. H. 1987. The chemistry of water treatment processes 
involving ozone, hydrogen peroxide and ultraviolet radiation. Ozone: Science & 
Engineering 9, 335–352. 
Gilmour, C. 2012. Water Treatment using advance oxidation processes: Application 
Perspectives, Thesis. The university of Western Ontario. 
 Guidance for Industry. 2012. S2(R1) Genotoxicity Testing and Data Interpretation for 
Pharmaceuticals Intended for Human Use. <www.fda.gov/downloads/Drugs/Guidances/ 
ucm074931.pdf>. 
 Gulkowskaa, A., Leunga, H. L.,  Soa, M.K., Taniyasub, S., Yamashitab, N., Yeunga, L. W. Y.,  
Richardsona, B. J., Leic, A. P., Giesya, J. P.,  Lama, P. K. S. 2008. Removal of antibiotics 
from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. Water 
Research 42, 395–403. 
 
 
32 
 
Halling-Sorensen, B., Nielsen, S. N., Lanzky, P. F., Ingerslev, F., Lutzhoft, H. C. H., Jorgensen, 
S. E. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment—
a review. Chemosphere 36(2), 357–394. 
Hartig, C., Storm, T., Jekel, M. 1999. Detection and identiﬁcation of sulphonamide drugs in 
municipal wastewater by liquid chromatography coupled with electrospray ionisation 
tandem mass spectrometry. J Chromatogr A 854, 163–173. 
Hernandez-Raquet, S., Combalbert, G. 2010. Occurrence, fate, and biodegradation of estrogens 
in sewage and manure. Appl Microbiol Biotechnol 86, 1671–1692. 
Hirscha, R., Ternesa, T., Haberer, K., Kratzb, K. L. 1999. Occurrence of antibiotics in the 
aquatic environment. The Science of the Total Environment  225, 109–118. 
Huang, C. H., Sedlak, D. L. 2001. Analysis of estrogenic hormones in municipal wastewater 
efﬂuent and surface water using enzyme-linked immunosorbent assay and gas 
chromatography/tandem mass spectrometry. Environ. Toxicol. Chem. 20, 133–139. 
Hudson, J. J., Keith, M., Dillon, P.J., Somers, K.M. 2003. Long-Term Patterns in Dissolved 
Organic Carbon in Boreal Lakes : The Role of Incident Radiation , Precipitation , Air 
Temperature , Southern Oscillation and Acid Deposition. Hydrology and Earth System 
Science 7 (3). 
Hubbard, S.A., M.H.L. Green, D. Gatehouse and J.W. Bridges. 1984, 141–160. In: Handbook of 
Mutagenicity Test Procedures (2nd Edition). B.J. Kilbey, M. Legartor, W. Nichols and C. 
Ramel (Eds.). Elsevier/North Holland, Amsterdam. 
Ike, M., Chen, M., Jin, C-S. J., Fujita, M. 2002. Acute Toxicity, Mutagenicity, and Estrogenicity 
of Biodegradation Products of Bisphenol-A. Environ Toxicol, 457–461. 
Irmak, S., Erbatur, O., Akgerman, A. 2005. Degradation of 17_-estradiol and bisphenol A in 
aqueous medium by using ozone and ozone/UV techniques. Journal of Hazardous 
Materials 126 (1), 54–62. 
 
 
33 
 
Jarvenpaa P., Kosunen T., Fotsis T., Adlercreutz H. 1980. In vitro metabolism of estrogens by 
isolated intestinal microorganisms and by human fecalmicroflora. J Steroid BiochemMol 
Biol 13, 345–349. 
Jasim, S. Y., Irabelli, A., Yang, P., Ahmed, S., Schweitzer, L. 2006. Presence of pharmaceuticals 
and pesticides inDetroit riverwater and the effect of ozone on removal. Ozone Sci. Eng. 28, 
415–423. 
Jobling, S., Sheaham, D. A., Osborne, J. A., Matthiessen, P., Sumpter, J. P. 1995. Inhibition of 
testicular growth in rainbow trout (Oncorhynchus mykiss) exposed to environmental 
estrogens. Environ. Toxicol. Chem. 15, 194–202. 
Jobling, S., Nolan, M., Tyler, C.R., Brighty, G., Sumpter, J.P. 1998. Widespread sexual 
disruption in wild fish. Environmental Science and Technology 32 (17), 2498–2506. 
Johnson, A. C., Belfroid, A., Di Corcia, A. 2000. Estimating steroid oestrogen inputs into 
activated sludge treatment works and observations on their removal from the effluent. 
Science of the Total Environment  256, 163–173. 
Jones, O. A. H., Lester, J. N., Voulvoulis, N. 2005.  Pharmaceuticals: a threat to drinking water? 
Trends Biotechnol  23(4), 163–167. 
Juckera, C., Clarkb, M. M. 1994. Adsorption of aquatic humic substances on hydrophobic 
ultrafiltration membranes. Journal of Membrane Science 97, 97, 37–52. 
Kemper, N. 2008.  Veterinary Antibiotics in the Aquatic and Terrestrial Environment. Ecological 
Indicators 8, 1–13.  
Ke, J. X., Zhuang, W. Q., Gin, K. Y. H., Reinhard, M., Hoon, L. T., Tay, J. H. 2007. 
Characterization of estrogen- degrading bacteria isolated from an artificial sandy aquifer 
with ultrafilitered secondary effluent as the medium. App Microbio Biotechnol 75, 1163–
1171. 
Kidd, K. A., Blanchfield, P. J., Mills, K. H., Palace, V. P., Evans, R. E., Lazorchak, J. M., Flick, 
R. W. 2007. Collapse of a fish population after exposure to a synthetic estrogen. 
 
 
34 
 
Proceedings of the National Academy of Sciences of the United States of America 104 
(21), 8897–8901. 
Kima, S. D., Choa, J., Kima, I. N., Vanderford, B. J., Snyder, S. A. 2007. Occurrence and 
removal of  pharmaceuticals and endocrine disruptors in South Korean surface, drinking, 
and waste waters. Water Research 41, 1013–1021. 
Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., 
Buxton, H. T. 2002. Pharmaceuticals, hormones, and other organic wastewater 
contaminants in US streams, 1999–2000: a national reconnaissance. Environ. Sci. Technol. 
36, 1202–1211. 
Kommineni, S., Zoeckler, J., Stocking, A., Liang, S., Flores, A., and Kavanaugh, M. 2008. 
Advanced   Oxidation Processes. National water research.  
Kümmerer, K. 2009. Antibiotics in the aquatic environment—a review—part II. Chemosphere 
75(4), 435–441. 
Lai, K. M., Johnson, K. L., Scrimshaw, M. D., Lester, J. N. 2000. Binding of waterborne steroid 
estrogens to solid phases in river and estuarine systems. Environ Sci Technol 34, 3890–
3894. 
Lai, K. M., Scrimshaw, M. D., Lester, J. N. 2002. Biotransformation and bioconcentration of 
steroid estrogens by Chlorella vulgaris. App Environ Microbiol 68, 859–864. 
Larcher, S., Yargeau, V. 2012. Biodegradation of sulfamethoxazole: current knowledge and 
perspectives. Appl Microbiol Biotechnol 96, 309–318. 
Latorre, A., Lacorte, S., Barcelo, D. 2003. Presence of nonylphenol, octyphenol and bisphenol a 
in two aquifers close to agricultural, industrial and urban areas. Chromatographia  57, 111–
116. 
Lee, H. B., Liu, D. 2002. Degradation of 17β- estradiol and its metabolites by sewage bacteria. 
Water Air Soil Poll 134, 353–368. 
 
 
35 
 
Lia, W., Seifertb, M., Xua, Y., Hock, B. 2004. Comparative study of estrogenic potencies of 
estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays. Environment 
International 30, 329–335. 
Lindstrom, M., Nystrom, M., Laatikainen, M. 1988. Inter- actions between chlorolignin and 
polysulphone ultratil-tration membranes, Sep. Sci. Technol. 23, 703–717. 
Luria, S. E., Delbrtck, M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. 
Genetics 28, 491–511. 
Melcer, H., Klecka, G. 2011. Treatment of Wastewaters Containing Bisphenol A: State of the 
Science Review Water Environment Research 83 (7), 650–666. 
Metrzler, M. 2001. The hand book of environmental Chemistry 3, part L. Endocrine Disruptors, 
part 1. 3 Springer-Verlag, Berlin, 169-201. 
Miao, X. S., Bishay, F., Chen, M., Metcalfe, C. D. 2004. Occurrence of antimicrobials in the 
final effluents of wastewater treatment plants in Canada. Environ.Sci. Technol. 38, 3533–
3541. 
Molot,  L. A., Dillon,  P. J., Clark, B. J., Neary, B. P. 1992. Predicting end-of-summer oxygen 
profiles in stratified lakes. Can. J. Fish. Aquat. Sci. 49, 2363–2372. 
Murray, K. T. 2010. Prioritizing research for trace pollutants and emerging contaminants in the 
freshwater environment. Environ. Pollut 158, 3462–3471. 
Nakada, N., Shinohara, H., Murata, A., Kiri, K., Managaki, S., Sato, N., Takada, H. 2007. 
Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-
disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage 
treatment plant. Water research. 41, 4373–4382. 
Neamtu, M., Frimmel, F. H. 2006. Degradation of endocrine disrupting bisphenol A by 254nm 
irradiation in different water matrices and effect on yeast cells. Water Research 40, 3745–
3750. 
 
 
36 
 
Rajapakse, N., Ong, D., Kortenkamp, A. 2001. Defining the impact of weakly chemicals on the 
action of steroid estrogens. Toxicological science. 60, 296–304.  
Rajapakse, N., Silva, E., Kortenkamp, A. 2002. Combining Xenoestrogens at Levels below 
Individual No-Observed-Effect Concentrations Dramatically Enhances Steroid Hormone 
Action. Environmental Health Perspectives 110(9). 
Reinthaler, F. F., Posch, J., Feierl, G., Wust, G., Haas, D., Ruckenbauer, G., Mascher, F., Marth, 
E. 2003. Antibiotic resistance of E. coli in sewage and sludge. Water Research 37(8), 
1685–1690. 
 Reungoat, J., Escher, B. I., Macova, M., Argaud, F. X., Gernjak, W., Keller, J. 2012. Ozonation 
and biological activated carbon filtration of wastewater treatment plant effluents. Water 
research. 46, 863–872. 
Rice, S. L., Mitra, S. 2007. Microwave-assisted solvent extraction of solid matrices and 
subsequent detection of pharmaceuticals and personal care products (PPCPs) using gas 
chromatography–mass spectrometry. Analytica Chimica Acta 589, 125–132. 
Rizzo, L. 2011. Bioassays as a tool for evaluating advanced oxidation processes in water and 
wastewater treatment. water research 45, 4311–4340. 
Rosal, R., Rodrı´guez, A., Perdigo´n-Melo´n, J. A., Petre, A., Garcı´a-Calvoa, E., Go´mez, M. J., 
Agu¨ era, A., Ferna´ndez-Alba, A. R. 2010. Occurrence of emerging pollutants in urban 
wastewater and their removal through biological treatment followed by Ozonation. Water 
Research 44, 578–588. 
Routledge, E. J., Sumpter, J. P. 1995. Estrogenic activity of surfactants and some of their 
degradation products assessed using a recombinant yeast screen. Environmental 
Toxicology and Chemistry 15, 241–48. 
Routledge, E Dwin J, and John P Sumpter. 1996. Estrogenic Activity of Surfactants and Some of 
Their Degradation Products Assessed Using a Recombinant Yeast Screen. Environmental 
Toxicology and Chemistry 15 (3), 241–248. 
 
 
37 
 
Snyder, S. A. 2003. Endocrine Disruptors as Water Contaminants: Toxico- logical Implications 
for Humans and Wildlife, Southwest Hydrol. 
Sajiki, J., Yonekubo, J. 2004. Inhibition of seawater on bisphenol A degradation by Fenton 
reagents. Environ. Int. 30, 145–150. 
Schwarzenbach, R. G., Gschwend, P. M., Imboden, D. M. 2003. Environmental Organic 
Chemistry. 2nd ed. Hoboken, Wiley. 
Schwarzenbach, R. P.,  Escher B. I., Fenner, K., Hofstetter, T. B., Johnson, C. A., Von, G. U., 
Wehrli, B. 2006. The Challenge of Micropollutants in Aquatic Systems. Science 313 (25), 
1072–1077. 
Shinwoo Yang, K. C. 2003. Evolution of antibiotic occurrence in a river through pristine, urban 
andagricultural landscapes. Water Research 37, 4645–4656. 
Shuang, C., Pan, F., Zhou, Q., Li, A., Li, P. 2012. Magnetic polyacrylic anion exchange resin: 
preparation, characterization and adsorp- tion behavior of humic acid. Ind. Eng. Chem. 
Res. 51, 4380–4387. 
Shuang, C., Wang, M., Li, P., Li, A., Zhou, Q., Pan, F., Zhou, W. 2014. Adsorption of Humic 
Acid Fractions with Different Molecular Weight by Magnetic Polyacrylic Anion Exchange 
Resin. Journal of Soils and Sediments 14, 312–19.  
 Silva, C. P., Otero, M., Esteves, V. 2012.  Processes for the Elimination of Estrogenic Steroid 
Hormones from Water: A Review. Environmental Pollution 165,  38–58.  
Silva, E., Rajpakse, N., Kortenkamp, D. 2002. Something from “Nothing” – Eight Weak 
Estrogenic Chemicals Combined at Concentrations below NOECs Produce Significant 
Mixture Effects.Environ. Sci. Technol. 36, 1751–1756. 
Snyder, S., Keith, T., Verbrugge, D., Synder, E., Gross, T., Kannan, K., Giesy, J. 1999. 
Analytical Methods for Detection of Selected Estrogenic Compounds in Aqueous Mixtures. 
Environ. Sci. Technol.  33, 2814-2820. 
 
 
38 
 
Sohoni, P., Sumpter, P. 1998. Several environmental oestrogens are also anti-androgens. J. 
Endocrinol 15, 327. 
Stangroom, S. J., Collins, C. D., Lester, J. N. 1998. Sources of Organic Micropollutants to 
Lowland Rivers. Environmental Technology 19 (7), 643–66. 
Stumpf, M., Ternes, T. A., Haberer, K., Baumann, W. Nachweis, 1996. Von naturlichen und 
synthetischen Ostrogenen in Klaranlagen und Fliessgewassern. Vom Wasser in German 87, 
251-261. 
Tamaoto, H., Takahashi, A., Yakou, Y., Miyamoto, N., Saito, T. 2001. Using DNA recombinant 
yeast, evaluation of estrogen- like activity of river water in Japan. 2
nd
 IWA World Water 
Congress in Berlin, 15-19 October.   
Ternes, T.A., Kreckel, P., Mueller, J., 1999a. Behaviour and occurrence of estrogens in 
municipal sewage treatment article in press 1020 water r esearch 41 (2007) 1013– 
1021plants—II. Aerobic batch experiments with activated sludge. Sci. Total Environ. 225, 
91–99.  
Tipping, E. 1981. Adsorption by goethite (a-FeOOH) of humic substances from three different 
lakes. Chemical Geology 33, 81–89. 
Thiele-Bruhn, S., Seibicke, T., Schulten, H. R., Leinweber, P. 2004. Sorption of sulfonamide 
pharmaceutical antibiotics on whole soils and particle-size fractions. Journal of 
Environmental Quality 33(4), 1331–1342. 
Thorpe, K. L., Cummings, C. I., Hutchinson, H. H. T., Scholze, S., Brighty, G., Sumpter, J. P., 
Tyler, C.R. 2003. Relative Potencies and Combination Effects of Steroidal Estrogens in 
Fish Environ. Sci. Technol. 37, 1142-1149. 
Tumpling, W. V., Wanke, F. A. 2004. Pharmaceuticals in the river Elbe and its tributaries. 
Chemosphere 57, 107–126. 
 
 
39 
 
Vigneault, B., Percot, A., Lafleur, M., Campbell, P. G. C. 2000. Perme- ability changes in model 
and phytoplankton membranes in the presence of aquatic humic substances. Enviro Sci 
Technol. 34, 3907–3913. 
Vogel, J. M. 2004. Tunnel Vision: The Regulation of Endocrine Disruptors, Policy Sci. 37, 277. 
Volkmann, H., Schwartz, T., Bischoff, P., Kirchen, S., Obst, U. 2004. Detection of clinically 
relevant antibiotic-resistance genes in municipal wastewater using real-time PCR 
(TaqMan). J Microbiol Methods 6(2), 277–286. 
Wiegel, A. Aulinger, R. Brockmeyer, H. Harms, J. Loffler, H. Reincke, R. Schmidt, B. 
Stachel,W.V. Tumpling, A.Wanke, Chemosphere 57 (2004) 107–126. 
McGinn, A. P.,  2000. POPs Culture. World Watch Magazine 13, 26–36. 
<http://www.worldwatch.org/node/485>  
 
Xu, W. H., Zhang, G., Li, X. D., Zou, S. C., Li, P. and Hu, Z. H. 2007. Occurrence and 
elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), 
South China. Water Res. 41, 4526–4534. 
Yu, Z. Q., Huang, W. L. 2005. Competitive sorption between 17α-ethinylestradiol and 
naphthalene/phenanthrene by sediments. Environ. Sci. Technol. 39, 4878–4885. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
Chapter Three 
 
 Degradation of 17-β estradiol, Sulfamethoxazole, Bisphenol A in 
Water by various Advanced Oxidation Processes: Effect of Humic 
acid 
  
3.1 Introduction  
The existence of endocrine disrupting compounds (EDCs) as well as 
pharmaceuticals and personal care products (PPCPs) in drinking water supplies and wastewater 
treatment effluent raises concern over the removal of these compounds by common drinking 
water and wastewater treatment processes (Heberer, 2002; Westerhoff et al. 2005; Shemer et al. 
2006; Rahman et al. 2009). Endocrine disrupter compounds (EDCs) are exogeneous agents that 
interfere with the secretion, synthesis, transport,   binding, or elimination of natural hormones in 
the body that are responsible for the reproduction, development, maintenance and behavior 
(Irmak et al. 2005), by acting as receptor mimics, agonist/ antagonists, shifting the metabolism 
and the synthesis of natural hormones (Sonnenschein and Soto, 1998). The presence of large 
number of pharmaceuticals and personal care products and other micropollutants like EDCs in 
water bodies may have potential to produce additive harmful effects (Kolpin et al. 2002). 
Sulfamethoxazole (SMX) is an antibiotic that has been ranked within the top five mostly 
consumed sulfonamides and most common prescribed antibiotics (Nicolle, 2002). Bisphenol A  
has been used extensively for the production of polycarbonates and epoxy resins over the past 
few decades (Metrzler, 2001). 
 
Humic acid (HA) is one type of natural organic matter (NOM) present in ground water, lakes, 
streams and other water bodies, which is of biological origin of aquatic plants and animals 
(Burgeset al. 1964).  Although humic and fulvic acids are the most hydrophobic portion of 
DOM, they are relatively hydrophilic, as their octanol-water partition coefficients log Kow is ≤2.8 
(Juckera and Clarkb 1994) as shown in Table 1. In addition, the polar and ionic character affects 
the solubility and hydrophilicity of HA. HA carbonyl oxygen is polar and the hydroxyl is both 
polar and ionic (Howe and Clark 2002). HA has 3.5- 4.5 meq/g of carboxyl content (Thurman 
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1985), and 2.4- 2.9 meq/g of phenolic content (Juckera and Clarkb 1994) ; Burges et al. (1964) 
detected 30 phenolic groups in humic acid. 
 
Humic macromolecules form negative charges bound cross-linked carbon network of HA when 
dissociated in aqueous media, which make it interact with various organic pollutants (Hayes et 
al. 1989). The phenolic and carboxylic groups, N-heterocyclic compounds, and lignin 
decomposition products in HA are preferred binding sites and responsible to site-specific 
sorption (Thiele-Bruhn et al. 2004). With the abundance of carboxyl acids in HA, the sorption of 
compounds like SMX to HA increases (Gao and Pedersen 2010). Kahle & Stamm (2007) 
showed that the sorption of SMX to HA increases with lower pH, and contact time. However, 
Pan et al. (2009); Zeng et al. (2006) found that there is a nonlinear relationship between the pH 
and the sorption of BPA to HA.Zhang & Zhou (2005) noted that HA influences the surface 
charge and the ionisation of chemicals; however the KD for E2 did not change significantly 
within the pH range studied. Based on their abundance in natural water and wastewater effluents, 
the modle compounds chosen for this work are sulfamethoxazole, 17-β estradiol and bisphenol 
A.  In addition humic acid also was used in the experiments to simulate the background organics 
concentration. With the relatively low water solubility and high log Kow of sulfamethoxazole, 17-
β estradiol and bisphenol A as shown in Table 3.1 promote association with biota and 
sedimentation (Birklett, 2003), therefore dictate partisan adsorption to humic acid. The high 
content of HA enhances the removal of sulfamethoxazole by coagulation (Vienoet al. 2006). On 
the other hand when HA is in low concentration (0.5–1.5 mg/ L) it enhances the 
photodegradation of the organics (Liu et al. 2012). 
 
In the past decades, advanced oxidation processes (AOPs) have been used successfully in water 
and wastewater treatment (Legrini et al. 1993). The advantages of the AOPs are (Vilhunen 
2010): 
1- Fast reaction rate. 
2- Permitting the treatment of multiple contaminants at the same time, due to the non-
selective nature. 
3- They also have the potential to reduce the toxicity of the contaminants. 
4- Completely mineralize the target compounds.  
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5- The majority of AOPs does not produce solid waste nor concentrate the waste with the 
subsequent requirement for the further treatment.  
6- Removes unpleasant odour, colour of water due to the presence of NOM (Yildiz et al. 
2007; Koparal et al. 2008). 
 
The hydroxyl radical (HO•) is a strong oxidant that degrades many refractory organic pollutants 
by reacting with electron-rich sites on organic compounds and initiates complex radical chain 
reactions in aqueous phase advanced oxidation processes (AOPs) with high reaction rates (Chang 
et al. 2007; Goldstein et al. 2007; Minakata & Crittenden 2011). 
AOPs categorize into a variety of groups including photochemical and photocatalytic AOPs in 
which UV irradiation is used, e.g., UV coupled with hydrogen peroxide (UV/H2O2) and photo-
Fenton’s reaction, O3, UV and ozone (UV/O3), and UV and titanium dioxide (UV/TiO2), and 
microwave (MW) (Andreozzi et al. 1999; Beltra´n et al. 2012; Neamţu and Frimmel 2006; 
Shemer et al. 2006; Staehelin & Hoigne 1982; Stasinakis 2008; Irmak et al. 2005; Larcher and 
Yargeau 2013; Huber et al. 2003; Bolton et al. 2003; Ferrari et al. 2009).  
AOPs have received extensive interest among scientific community, their benefits are 
indubitable, and however, in order to apply AOPs in large scale, bench and pilot scale studies are 
always required for target compounds as the rate of degradation is compound and AOP specific. 
The objective of this study is to evaluate the effect of the presence of humic acid on the 
efficiency of three advanced oxidation processes UV/H2O2, UV/O3 and O3 on the degradation 
and mineralization of different mixture of the three compounds (shown in Table 3.1) of 
increasing concern. The AOPs chosen in this study are commonly applied in water and 
wastewater treatment plants and can be easily retrofitted for the addition removal of the 
micropollutants.  
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Table 3.1: Physicochemical properties of Sulfamethoxazole, 17-β estradiol, Bisphenol A and 
Humic acid 
 
 
Characteristics 
Sulfamethoxazole 17-β estradiol Bisphenol A Humic acid 
Molecular 
formula 
C10H11N3O3S C18H24O2 C15H16O2 
Average chemical formula 
C187H186O89N9S1 
Molecular 
structure 
 
 
 
 
Molecular 
weight 
(g/mol) 
253.279 272.38 228.29 <1000- >10,000
a
 
Water 
solubility 
(mg/L) 
610 3.6 
20–300 ppm 
(21.5 °C) 
more soluble in the aqueous 
phase 
b&c
, however with low 
pH leads to lower the 
solubility 
e 
pKa 5.6-6.0 10.4 9.6 
4.65
d 
log Kow 0.5-0.9 3.9-4.0 3.32 
≤2.8
e 
a. (Shuang et al. 2014) 
b. Lindstrom et al. 1988 
c. (Tipping 1981) 
d.  (Berthat and Choppin 1978) 
e. (Juckera and Clarkb 1994) 
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3.2 Experimental  
 
3.2.1 Chemicals: 
 
17-β estradiol (chemical formula: C18H24O2, CAS: 50-28-2) was obtained from Sigma- 
Aldrich (Oakville, Ontario, Canada) of 98% purity. Sulfamethoxazole (chemical formula: 
C10H11N3O3S, CAS: 723-46-6) was obtained from Fluka Analytical, bisphenol A (chemical 
formula: C15H16O2, CAS: 80-05-7) was obtained from Sigma–Aldrich (Oakville, Ontario, 
Canada) of 99+% purity, and humic acid (Average chemical formula C187H186O89N9S1, CAS: 
1415-93-6) was obtained from Alfa Aesar. Hydrogen peroxide (H2O2, CAS: 7722-84-1) and 
catalase (CAS: 9001-05-2) were obtained from Sigma–Aldrich (Oakville, Ontario, Canada).  
HPLC grade organic solvent acetonitrile (AcN) was purchased from Caledon Laboratories 
(Georgetown, Ontario, Canada). All reagents were used as received without further purification. 
Laboratory-grade Ultrapure (MiliQ) water (conductivity of 18M Ω) was obtained  from a 
Millipore purification system (model Integral 5, EMD Millipore Corporation, Billerica, MA, 
USA).  
 
3.2.2  HPLC Analysis:  
 
17-β estradiol, sulfamethoxazole, bisphenol A and humic acid concentrations were measured by 
HPLC (ICS 300, Dionex), which included a DP pump, an AS auto sampler, a DC column oven, 
and PDA UV detector, connected to Chromeleon software. Separations were carried out with an 
Acclaim 120 C18 reversed-phase column (150 mm × 4.6 mm i.d., 5 μm particle size, Dionex, 
USA). The injection volume was 100 μL from 10 mL HPLC vials, capped and sealed with PTFE 
lids. The mobile phase used was a mixture of AN and Mili-Q water (60:40 
v/v) at a flow rate of 1 mL/min by the HPLC pump at an isocratic mode. The column 
temperature was maintained at 30°C and the detection wavelength was set at 200 nm for SMX, 
E2 and HA, 220 nm for BPA with a retention time of 2.27 min, 3.53 min, 0.8 to 1.00 min, and 
3.27 min, respectively.  
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3.2.3 Other analyses: 
 
 Shimadzu TOC-VCPN analyser with an ANSI-V auto sampler was used to measure the TOC of 
the initial and treated samples. The pH was determined with a pH meter (model sympHony™ 
Benchtop Meters, B10P, obtained from VWR. The pH values of different mixtures are shown in 
Table 3.2.  It can be seen that the pH varied in a narrow range of 5.2-6.3. 
 
Table 3.2:  The Natural pH of different compounds in solution at their environmental 
concentration 
Solution           pH 
SMX  5.2 
BPA 6 
E2 6.4 
HA 6.2 
BPA- SMX 5.6 
BPA- E2 6.1 
BPA- HA 6.1 
E2- SMX 5.3 
E2- HA 6.3 
HA- SMX 5.5 
BPA- SMX- HA 5.8 
BPA- E2- HA 6.2 
SMX- E2- HA 5.7 
BPA- E2- SMX 5.4 
BPA- SMX- E2- HA 6 
0.5  conc. BPA+ E2 + SMX+ HA 6.3 
0.5  conc. BPA+ E2 + SMX+ HA 6.3 
0.5  conc. BPA+ E2 + SMX+ HA 6.3 
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3.2.4 AOPs experiments: 
 
Pure solutions and mixtures of 17-β estradiol (0.7 mg/L), sulfamethoxazole (80 mg/L), bisphenol 
A (11.6 mg/L), and humic acid (1000 mg/L) were chosen as mentioned earlier according to the 
environmental values. They were prepared in Milli – Q water with stirring and heating at 80 °C 
to be used in the experiments with no further dilution. 
All AOP experiments were performed in a bench-scale annular reactor with 750 mL 
reactor volume. Samples were taken in five different times for all the AOPs at t= 0 min, 10 min, 
20 min, 50 min and 90 min. 
 
a.  Ozonation (O3): 
 
The experiments were performed in a bench-scale annular reactor. Ozone was produced by an 
ozone generator (model TG-40, Ozone Solutions, Hull, Iowa, USA) in which oxygen was fed to 
the generator from a compressed oxygen tank set at a pressure of 15 psi. The produced ozone 
was at a concentration of 2500 ppm, measured using an ozone analyzer (model UV-100, Eco 
Sensors, Newark, California, USA). The ozone was fed into 750 mL annular reactor. The 
corresponding aqueous concentration of ozone was calculated using Henry’s constant and varied 
from 0.33-1.31 mg/L. The solutions had an ambient temperature  with an initial pH as shown in 
Table 3.2. The experimental setup is shown in Figure 3.1. 
 
a. Photolysis/ Hydrogen peroxide (UV/ H2O2): 
 
The experiments were performed in a bench-scale annular reactor Figure 3.2. A 13W low-
pressure Hg lamp (model Philips TUV PL-S, 1000Bulbs.com, Texas, USA), with 
monochromatic light at 253.7 nm was used as the light source. The UV intensity at 254 nm 
radiation on the quartz surface was measured to be 18 mW/cm
2
. The reaction volume was 750 
mL. A water cooling jacket was used to maintain the reaction temperature at 20°C; the initial pH 
of the solutions was measured, the reaction mixture was spiked with 33% H2O2 resulting in final 
H2O2 concentration of 10 ppm in the reaction media and the reactor contents were thoroughly 
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mixed using a magnetic stirrer. The samples were immediately quenched with catalase to 
decompose residual H2O2.  
 
Figure 3.1: Experimental set-up for O3 and UV/O3 
 
 
 
a. Photolysis/ Ozonation  (UV/ O3): 
The experiments were performed in a bench-scale annular reactor as shown in Figure 3.1. A 
13W low-pressure Hg lamp (model Philips TUV PL-S, 1000Bulbs.com, Texas, USA), with 
monochromatic light at 253.7 nm was used as the radiation source. The UV intensity on the 
quartz surface was measured to be 18 mW/cm
2
. The reaction volume was 750 mL. A water 
cooling jacket was used to maintain the reaction temperature at 20°C. Ozone was produced 
by an ozone generator (model TG-40, Ozone Solutions, Hull, Iowa, USA) in which oxygen 
was fed to the generator from a compressed air tank set at a pressure of 15 psi. The produced 
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ozone concentration in gas phase was 2500 ppm, measured using an ozone analyzer (model 
UV-100, Eco Sensors, Newark, California, USA). 
 
 
 
Figure 3.2: Experimental set-up for UV/H2O2 
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3.3 Results and Discussions  
3.3.1 Kinetics of 17-β estradiol, Sulfamethoxazole, Bisphenol A and Humic 
acid Degradation in aqueous medium: 
In this chapter, kinetics of degradation of the model compounds at their environmentally relevant 
concentrations are reported. The experiments were conducted using correlated environmental 
concentrations of 17-β estradiol (0.7 mg/L), sulfamethoxazole (80 mg/L), bisphenol A (11.6 
mg/L) and humic acid (1000 mg/L) as pure compounds and as well in mixture. The interactions 
of the compounds were determined using full factorial design (FFD) (2
4
; two levels and four 
factors), for three different advance oxidation treatments namely O3, UV-O3 and UV/ H2O2. 
Table 3.3 presents the coded values for high and low levels for the 2
4
 full factorial design 
matrixes (Experiments 1–19). For the four-factor case, the response surface is given by the linear 
model (Myers and Montgomery, 1995; Ferreira et al. 2007). 
 
Table 3.3: Full factorial design matrix (2
4
) 
Experiment sequence BPA SMX E2 HA 
1 -1 -1 -1 -1 
2 +1 -1 -1 -1 
3 -1 +1 -1 -1 
4 +1 +1 -1 -1 
5 -1 -1 +1 -1 
6 +1 -1 +1 -1 
7 -1 +1 +1 -1 
8 +1 +1 +1 -1 
9 -1 -1 -1 +1 
10 +1 -1 -1 +1 
11 -1 +1 -1 +1 
12 +1 +1 -1 +1 
13 -1 -1 +1 +1 
14 +1 -1 +1 +1 
15 -1 +1 +1 +1 
16 +1 +1 +1 +1 
17 0.5 0.5 0.5 0.5 
18 0.5 0.5 0.5 0.5 
19 0.5 0.5 0.5 0.5 
Where -1 is the low level = 0, and +1 is the high level = (BPA C0= 11.6 mg/L and/or SMX C0= 80 mg/L and/or E2 
C0= 0.7 mg/L and/or HA C0= 1000 mg/L) 
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a. Ozonation  (O3): 
Ozonation is chosen in this study as it is widely used in drinking water and it is an advanced 
wastewater treatment. In addition, a large number of studies showed that it has the ability to 
oxidize compounds with structures containing carbon–carbon double bonds, aromatics, hydroxyl, 
and amino groups. All of the selected model compounds possess some of these structural 
characteristics (Irmak et al. 2005; Huber et al. 2003; Larcher and Yargeau 2013; Staehelin and 
Hoigne 1985). 
Ozone follows two pathways when reacting with organic compounds, the first one is through 
hydroxyl radicals and the other one is the direct oxidation by molecular ozone (Irmak et al. 
2005). In the radical pathway, it follows a chain of reaction which includes initiation, 
propagation and termination steps (Staehelin & Hoigne, 1985; Tomiyasu et al. , 1985) 
- Initiation step: It will start by OH
¯ 
ions yielding 
•
OH radicals. 
 
O3 + OH
¯ → O2
• 
¯ + HO2 
•    ………………………………………………………………..  (3.1) 
HO2 
• 
is in acid-base equilibrium 
HO2 
•  O2
• 
¯ + H
+    ……..……………………………………………………….……….…. (3.2) 
 
 
- Propagation step: 
O3 + O2
• ¯ → O3
• 
¯+ O2 ……..……………………………………………………………...  (3.3) 
HO3 
• 
= O3
• 
¯ + H
+ ……..……………………………………………………………….…..  (3.4) 
HO3 
• → •OH + O2 ……..……………………………………………………………..……  (3.5) 
O3 + 
•OH → HO4 
• ……..………………………………………….……………....….....…...(3.6) 
HO4 
• → HO2 
• 
+ O2 ……..…………………………………………………………….…...  (3.7) 
- Termination steps:  
These steps include any recombination of   
•
OH, HO2
• 
and O2.    
  
 
b. Photolysis- hydrogen peroxide (UV/ H2O2): 
Coupling UV irradiation with H2O2 is an effective technique for degradation of single and 
mixture of compounds, because it produces hydroxyl radical (
•
OH) (Chen et al. 2006; Chen et al. 
2007; Rosenfeldt and Linden 2004), therefore UV/ H2O2 was applied in our study.  
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The hydroxyl radical is generated in UV/ H2O2 by photolysis of the peroxidic bond, when UV 
light is absorbed directly by hydrogen peroxide (Eq. (3.8)). 
H2O2 + hν → 2
•OH …………………………………………………………………………...(3.8) 
Due to stronger absorption by the peroxide at lower wavelengths, the short-ultraviolet 
wavelength (200–280 nm) yields the highest hydroxyl radical (Shemer et al. 2006). Therefore, 
254 nm UV wavelength was chosen in our study. 
In UV/ H2O2 reaction the ultraviolet radiation cleavages the O-O bond in hydrogen peroxide in 
order to generate hydroxyl radical as described by (Buxton et al. 1988): 
 
H2O2 + hν → 2
•OH ……………………………………………………………………..…..... (3.9) 
H2O2 + HO
• → HO2 
•
 + H2O………………………………………………………………..... (3.10) 
H2O2 + HO2 
•
 → HO• + H2O + O2 ……………………………………………………..…...... (3.11) 
2 HO 
•→ H2O2 ……………………………………………………………………………...  (3.12) 
2 HO2 
•→ H2O2 + O2 ………………………………………………………………..…….... (3.13) 
HO
• 
+ HO2 
•→ H2O + O2 …………………………………………………………..…...….  (3.14) 
The rate of reaction in Eq. (3.9) is the slowest one among all of the above reactions; therefore it 
is the rate limiting reaction. 
 
c. Photolysis- Ozone  (UV- O3): 
The combination of ultraviolet (UV) radiation with O3 was used in our study because it is an 
effective oxidation method in advanced water treatment for its destruction ability of toxic 
organics in water. The extinction coefficient of O3 at 254 nm is 3600 M
−1
 cm
−1
 which is much 
higher than that of H2O2 in UV/ H2O2 treatment (Andreozzi et al. 1999). UV/ O3 provides much 
higher absorption cross section than UV-H2O2 (photochemical point of view), and inner filter 
effects (Legrini et al. 1993). 
Coupling of UV with O3 reduces the O3 consumption requirement and transformation time 
compared to using only O3. In addition due to the formation of additional H2O2 and 
•
OH radical 
via photolysis (Staehelin & Hoigne 1982), UV/ O3 is more effective than O3 alone for certain 
target materials (Irmak et al. 2005). 
•
OH radical in UV/ O3 is produced via different reaction 
pathways; therefore it is more complex than other oxidation processes (Peyton & Glaze 1988). 
The general reactions that are involved (Staehelin & Hoigne 1982): 
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O3 + H2O + hν →
 
H2O2 + O2 ………………………………………………………………. (3.15) 
H2O2 + hν → 2
•OH …………………………………………………………………..…….. (3.16) 
H2O2 → HO2 ¯ + H
+
 ……………………………………………………………………..... (3.17) 
This will react with further ozone by producing O3
• 
¯ radicals. 
H2O2 + O3→ HO2 
• 
+ O3
• ¯ ……………………………………………………………..….. (3.18) 
As it acts as a chain carrier (Staehelin & Hoigne 1985).  
3.3.1.1 The kinetics of sulfamethoxazole degradation: 
 
a. The kinetics of sulfamethoxazole degradation as a pure compound: 
SMX showed ~ 100% removal in all the AOPs (O3, UV/ O3 and UV/ H2O2) as shown in 
Figure 3.3. The slowest removal occurred for only ozonation whereas the combination of UV 
with ozone and hydrogen peroxide produced much faster degradation rate. The kinetic data 
shown in Figure 3.4 exhibited exponential decay indicating possible first order kinetics.   
 ln 
 
   
=     ………………………………………………………………………………… (3.19) 
Where C0 is the concentration at zero time and t is the reaction time in min, k is the first order 
degradation constant in (min -
1
).The kinetic data were plotted using pseudo-first order rate 
expression showed very good fitting with high values of correlation coefficient, R
2
 as shown 
in Figure 3.4. UV/ O3 showed the fastest degradation rate (0.264 min
-1
), while the slowest 
degradation rate was found in ozonation with a rate constant of 0.036 min
-1
.  SMX in its non-
ionized form in aqueous solution has UV absorption maximum at 268 nm which extends 
through the ultraviolet-B (UVB) region. With a molar extinction coefficient 254 = 7345 M
-1
 
cm
-1
, it was found to be extremely susceptible to photodegradation with quantum yield as high 
as 0.47 at pH 3.0 and 0.084 at pH 9.0 (Moore & Zhou 1994).  The lower quantum yield at pH 
9.0 is due to the stability of SMX anion. SMX is a weak acid with a pKa value of 5.6, and 
therefore completely anionized at pH 9.0.  The authors also reported a rate constant of 0.15 
min
-1
 at pH 3.0 and incident intensity of 25 W/m
2
. In this work, although a 7.2 times higher 
UV intensity (18 mW/cm
2
=180 W/m
2
), the rate constant was only 1.76 times higher than that 
of Moore and Zhou (1994).  This is possibly due to higher pH of 5.3 used in this work where 
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SMX is almost 50% ionized.  In addition, it is not the surface intensity rather than the 
illuminated volume is a more relevant factor affecting the photolysis rate constant. Different 
reactor size involved in this work compared to the work of Moore and Zhou would result in 
different illuminated volume. Ozone is expected to react with the NH2 group on the SMX 
molecule at a much lower rate in the order of 20 M
-1
 s
-1
 with typical half-life of 90 hours.  
Therefore, the higher rate observed in the case of UV and ozone is predominantly due to the 
effect of UV.   This was further proved in the experiments with UV+H2O2 when the rate of 
oxidation did not increase significantly even with the 10 fold increase in H2O2.  Similar 
results were reported by (Giri et al. 2011) when hydrogen peroxide addition to ultraviolet 
photolysis was not very significant due to low molar absorption coefficient for hydrogen 
peroxide at 254 nm (20.06 M
-1
cm
-1
) and acidic pH of reaction solution (< 5.7).  Ozone with 
higher molar absorption coefficient 3300 M
-1
cm
-1
 than H2O2 produces 2 moles of reactive OH
.  
radicals per mole of incident photon, compared to 0.09 moles of OH
. 
for H2O2.    
 
There is a significant difference between the degradation of the parent compounds and 
complete mineralization to carbon dioxide and mineral acids. Refractory compounds which 
are oxidized quite slowlyare known to form during the degradation of many micropollutants 
(Kusakabe et al. 1990). It can be seen in Figure 3.5, for all the three AOPs tested UV+O3 
degraded the total organic carbon (TOC) the most by 40% after 90 min of treatment. Dantas et 
al. (2008) achieved just 10% of mineralization with complete degradation of SMX after 15 
min of ozonation. Beltran et al. (2012) achieved 10-20% TOC reduction after 1 hr of O3 
treatment and 25-35% TOC removal after UV-O3 treatment; TOC reduction was the lowest 
for UV+H2O2.  
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Figure 3.3: Degradation of SMX, C0 = 80 mg/L, Ozone dosage is 1.31 mg/L, UV- intensity on 
the quartz surface was 18 mW/cm
2
, H2O2 dosage is 10 mg/L, pH = 5.2, AOPs are O3, UV/ O3 
and UV/ H2O2 
 
 
 
 
Figure 3.4: Determination of pseudo-first order rate constant, k (min
-1
) of SMX 
C0 = 80 mg/L, for O3, UV/ O3 and UV/ H2O2 
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Figure 3.5: Comparison between mineralization and degradation efficiencies for SMX, C0 
(SMX) = 80 mg/L, pH = 5.2 and AOPs treatment time = 90 min 
 
UV/ O3 caused ~ 100% SMX removal in all the mixtures (SMX- E2, SMX- BPA and SMX- 
BPA- E2) after 90 min of treatment. O3 also showed ~ 100% SMX removal in all the mixtures 
except SMX- BPA gave (~ 90 %) after 90 min. of treatment Although, in all mixtures SMX 
degraded, degradation rate constants as shown in Table 3.4 were affected negatively in presence 
of co-pollutants. The effect was more significant for the UV based processes as the rate constant 
decreased as high as 85% for UV/H2O2 compared to a drop of 23-31% in ozonation only.  Since 
ozone concentration was kept constant at 1- 3 mg/L by passing ozone continuously through 
reactor, the competitive effect of the pollutants was not as pronounced as in the UV based 
processes.  It was hard to determine the predominance of one compound over other due to their 
different initial concentrations and different molar absorption coefficient values. The increase in 
rate of SMX degradation in SMX-BPA mixture is probably due to experimental error.  
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Table 3.4: A comparison between the degradation rate constant, k (min
-1
) of sulfamethoxazole in 
the mixture after O3, UV/ O3 and UV/ H2O2  
Chemical  
O3 
k (min
-1
) 
UV/ O3 
k (min
-1
) 
UV/ H2O2 
k (min
-1
) 
SMX 0.036 0.264 0.177 
SMX- E2 0.028 0.096 0.095 
SMX- BPA 0.043 0.143 0.029 
SMX- BPA- E2 0.025 0.144 0.044 
 
3.3.1.2 The kinetics of 17-β estradiol degradation: 
Unlike SMX, E2 showed much higher degradation in ozonation and all three AOPs demonstrated 
comparable performance in degrading E2.  Due to faster rate of reaction, only 2-3 samples could 
be collected for the entire duration of the experiment as shown in Figure 3.6.  The pseudo first 
order rate constant was estimated based on the 90% degradation of E2 using different AOPs , 
and the rate constants varied in the following order: 0.189 min
-1
 (UV+O3)> 0.160 min
-1
 (O3)> 
0.08 min
-1
 (UV+H2O2).  This result is in agreement with our earlier work with estrone (E1) 
(Sarkar et al. , 2014). Unlike SMX, E2 showed much better removal in ozonation and 
combination of UV increased the rate only by 18%. The rate constant was the lowest with 
UV/H2O2.  Ozone reacts with the phenolic group present in the structure of E2.   
 
Figure 3.6: Degradation of E2, C0 = 0.7 mg/L, Ozone dosage is 1.31 mg/L, UV intensity on the 
quartz surface was 18 mW/cm
2
, H2O2 dosage is 10 mg/L, pH = 6.4, (a) UV/ H2O2, (b) UV/ O3 
and (c) O3 
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Similar to SMX, reduction in TOC with pure E2 was low.  For 85-90% removal of E2, only 
25%, 29% and 38% TOC reduction occurred for UV/ H2O2, O3, and UV/ O3, as shown in Figure 
3.7. Chowdhury et al.  (2010) observed a difference between the rates of degradation and 
minerilazation for E2 after solar irradation, in which it was attributed to the  breakage of the 
aromatic ring of E2 and the high stability of alicylic ring. Compared to SMX, TOC reduction of 
E2 was higher for all three AOPs. Although, SMX is lighter than E2, it is structurally more 
complicated than E2.  
 
Figure 3.7: Comparison between mineralization and degradation efficiencies for E2, C0 (E2) = 
0.7 mg/L, pH = 6.4 and AOPs treatment time = 90 min 
The effect of co-pollutant is always negative as has been the case for SMX. It is interesting to 
note that introducing SMX at a much higher concentration (114 times more than E2), the rate of 
degradation by ozonation only decreased by 23% when SMX was mixed with E2. However, the 
effect was more significant for UV-based processes, with 42% and 58% reduction for UV/O3, 
and UV/ H2O2, respectively. These results also confirm that SMX degradation in UV based 
processes is higher than ozonation. The effect of mixture is much more complex, and can’t be 
ascertained without determining reaction mechanism as shown in Table 3.5.  
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Table 3.5: A comparison between the degradation rate constant, k (min
-1
) of 17-β estradiol in 
mixture after O3, UV/ O3 and UV/ H2O2  
Chemical  O3 
k (min-1) 
UV/ O3 
k (min-1) 
UV/ H2O2 
k (min-1) 
E2 0.16 0.189 0.08 
E2- SMX 0.13 0.11 0.034 
E2- BPA 0.108 0.134 0.008 
E2- SMX- BPA 0.074 0.086 0.01 
 
 
3.3.1.3 The kinetics of Bisphenol A degradation: 
As for E2, BPA also showed good removal capacity with ozonation, and  UV/O3 .By the addition 
of H2O2 the rate was reduced by 86% from that of UV/ozonation as shown in Figure 3.8 and 
Figure 3.9. BPA has much lower UV-C molar absorption coefficient (750 M
-1
 cm
-1
), and H2O2 
with 10 ppm concentration competes with BPA at 11 ppm for UV photon.  
 
 
Figure 3.8: Degradation of BPA, C0 = 11.6 mg/L, Ozone dosage is 1.31 mg/L, UV intensity on 
the quartz surface was measured to be 18 mW/cm
2
, H2O2 dosage is 10 mg/L, pH = 6.0, AOPs: 
O3, UV/ O3 and UV/ H2O2 
 
Toor & Mohseni (2007) found that UV photolysis (0–2500 mJ cm-2) and H2O2 (2– 44 mg l
-1
) 
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byproducts (DBPs) in drinking water. They found that UV-H2O2 at sufficiently high UV fluences 
(greater than 1000 mJ cm
-2
) and initial H2O2 concentration of ≥23 mg l
-1 
is effective at reducing 
DBPs. 
Once again, UV/O3 performed the best for mineralization of BPA.  With the lowest molecular 
weight of all three compounds tested, mineralization of BPA was the highest at >80% after 90 
min as shown in Figure 3.10.  
 
Figure 3.9: Determination of pseudo-first order rate constant, k (min
-1
) of BPA 
C0 = 11.6 mg/L, AOPs: O3, UV/ O3 and UV/ H2O2 
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Figure 3.10: Comparison between mineralization and degradation efficiencies for BPA, C0 
(BPA) = 11.6 mg/L, pH = 6.0 and AOPs time = 90 min 
 
Chen et al. (2006) achieved significant removal of BPA by coupling UV with H2O2 compared to 
using only UV. However, in this work, in general it was noted that UV/ H2O2 gave the lowest 
degradation, in addition to the slowest degradation rate of BPA in all the mixtures comparing 
with UV/ O3 and O3 as shown in Table 3.6. Andreozzi et al. (1999) mentioned that H2O2 has a 
small molar extinction coefficient (18.6M
−1
 cm
−1
) therefore only a relative small fraction of 
incident light is exploited, and in the presence of the other organic substrates they will act as 
inner filters for the UV light. Furthermore, H2O2 can become a scavenger for hydroxyl radicals 
when it exceeds 500 mM H2O2 (Neamţu & Frimmel 2006) due to formation of less reactive HO2 
•
 radicals. The effect of E2 on BPA degradation was minimal for UV based processes, whereas 
SMX affected the rate of UV degradation as it absorbs more UV-C radiation than BPA.  
UV/H2O2 gave higher rate of degradation for BPA-E2-SMX mixture, but this could be due to 
experimental errors.  
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Table 3.6: A comparison between the degradation rate constant, k (min
-1
) of bisphenol A in 
mixture with O3, UV/ O3 and UV/ H2O2  
Chemical  O3 
k (min-1) 
UV/ O3 
k(min-1) 
UV/ H2O2 
k (min-1) 
BPA 0.082 0.085 0.011 
BPA-  E2 0.067 0. 078 0.009 
BPA-  SMX 0.045 0.085 0.003 
BPA- E2- SMX  0.072 0.02 ----- 
  
 
3.3.1.4 The kinetics of humic acid degradation: 
The kinetics of humic acid degradation under different AOPs such as UV/ H2O2, UV/ O3, and O3 
are shown in Figure 3.11, and the pseudo-first order rate constants are determined in Figure 3.12. 
At a very high concentration of 1000 mg/L, humid acid demonstrated the lowest degradation rate 
of all the compounds tested, and UV/ O3 and UV/ H2O2 demonstrated comparable rates as shown 
in Table 3.7.  
 
 
Figure 3.11: Degradation of HA, C0 = 1000 mg/L, Ozone dosage is 1.31 mg/L, UV- intensity on 
the quartz surface was 18 mW/cm
2
, H2O2 dosage is 10 mg/L, pH = 6.2, AOPs: O3, UV/ O3 and 
UV/ H2O2 
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Figure 3.12: Determination of pseudo-first order rate constant, k (min
-1
) of HA 
 
Table 3.7: A comparison between the degradation rate constant, k (min
-1
) of humic acid in 
mixture with O3, UV/ O3 and UV/ H2O2  
Chemical   O3 
   k (min-1) 
UV/ O3 
k (min-1) 
UV/ H2O2 
k (min-1) 
HA  0.0009 0.008 0.01 
 HA- E2  0.0007 0.006 0.008 
HA- SMX 0.003 0.009 0.002 
HA- BPA 0.002 0.004 0.002 
HA- E2- SMX 0.004 0.017 0.001 
HA- BPA- SMX 0.006 0.028 0.008 
HA- BPA- E2  0.0007 0.006 0.008 
HA- BPA- E2- SMX 0.009 0.005 0.009 
 
UV/O3 mineralizes HA by 19% and ~ 48% of degradation of HA after 90 min of treatment as 
shown in Figure 3.13.  Chin and Bérubé (2005) observed a significant mineralization of DOC 
after UV/O3 treatment.  Ikemizu et al. (1987) mentioned that after UV/O3 treatment a rapid 
reduction in the HA TOC; however it did not mineralize totally even after 5 hours. UV/ H2O2 
and O3 reduced the TOC of HA by 6% and 13% with reduction percentage of ~ 24% and ~ 
33%, respectively.  HA degradation in presence of the co-pollutants is mostly negatively 
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affected and there is no clear trend as to whether there is any synergy as some of the mixtures 
such as HA-BPA-SMX showed much higher than anticipated rates.  
 
 
Figure 3.13: Comparison between mineralization and degradation efficiencies for HA, C0 (HA) 
= 1000 mg/L, pH = 6.2 and AOPs treatment time= 90 min 
 
Goslsn et al. (2006) and Toor and Mohseni (2007) showed that the combination of UV 
irradiation and H2O2 treatment promotes the 
•
OH-radicals formation which will enhance NOM 
reduction. However, in this study, out of seven mixtures, four of them (HA- SMX, HA- BPA, 
HA- E2- SMX and HA- BPA- SMX) gave the lowest degradation in UV/ H2O2, and only one 
mixture (HA- E2- SMX) showed higher degradation rate of HA compared to the other two 
AOPs. Wang et al. (2000) found that when the HA concentration was increased the UV/ H2O2 
rate constant was decreased. Furthermore Liao & Gurol (1995) found that at higher HA 
concentration and low H2O2 concentration; the scavenging effect of humic acid may influence 
the initial rate constant itself. At a short irradation time, the effective OH radicals scavengers are 
humic acid and hydrogen peroxide, which is represented by these reactions (Brezonik & 
Fulkerson-brekken 1998):  
H2O2 + hv → 2 
•
OH     OH FG0/V     …….………………………………………..…….... (3.20) 
•OH    + Humic acid → Humic acid radical + H2O ……………………………………...…. (3.21) 
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•
OH + H2O2 → HO2
•
+ H2O ………………………………………………………………. (3.22) 
 
Ozone reacts with natural organic matters by a selective direct reaction by addition to an 
electrophilic double bond, and non-selective and fast reaction occurs with 
•
OH-radicals which 
come from the decomposition of ozone in water (Matilainena & Sillanpää 2010).  
HA in all the mixtures did not show a complete degradation and fluctuated between ~13 and 
81%, due to very high concentration of HA used in our study (1000 mg/L) in order to correlate 
the concentration of the micropollutants used with the environmental values. The solution for 
better HA degradation is a longer time for AOPs treatment, and higher oxidant dosage, 
(Tuhkanen, 2004; Sarathy and Mohseni, 2007; Toor and Mohseni, 2007) and high UV intensity 
(Goslan et al., 2006; Huang et al., 2008), in order to generate enough 
•
OH-radicals. However, 
excess H2O2 can cause scavenging of the 
•
OH-radicals, making the process less effective 
(Tuhkanen, 2004; Rosenfeldt and Linden, 2007; Song et al., 2008). 
 
3.3.2 Effect of initial concentration on the degradation of 17-β estradiol, 
sulfamethoxazole, bisphenol A and humic acid in a mixture: 
 
Experiments were carried out at two different initial concentrations for E2, SMX, and BPA and 
HA mixtures, in order to study the effect of the initial concentration on the degradation rate 
constant. Initial tests were conducted at a concentration of 0.7 ppm for E2, 80 ppm for SMX, 
11.6 ppm for BPA and 1000 ppm for HA. Next tests were conducted in a mixture with half of the 
concentrations mentioned above. All experiments produced a linear plot of t against ln(C/C0) as 
shown in Figure 3.14 indication that the degradation of E2, SMX, BPA and HA in aqueous 
solution with UV/ H2O2, UV/ O3 and O3 treatments followed pseudo-first order kinetics. All the 
solutions in the three AOPs (UV/ H2O2, UV/ O3 and O3) showed faster degradation rate constant 
when the solution was in higher concentration as shown in Figure 3.14.  The degradation rate 
constant of SMX in BPA- E2- SMX- HA mixture decreased by 46%, 26% and 11% for O3, UV/ 
O3 and UV/ H2O2, respectively when the concentration was reduced to half of the original 
concentration. The degradation rate constant of E2 in BPA- E2- SMX- HA mixture decreased by 
60%, 23% and 40% for O3, UV/ O3 and UV/ H2O2, respectively. The degradation rate constant of 
BPA in BPA- E2- SMX- HA mixture decreased by 34%, 11% and 60% for O3, UV/ O3, and UV/ 
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H2O2,respectively. The degradation rate constant of HA in BPA- E2- SMX- HA mixture 
decreased by 29%, 2% and 9% for O3, UV/ O3 and UV/ H2O2 respectively. These results are in 
line with (Sarkar 2013; Rozita Keyavoos 2012) where a significant reduction in the speed of the 
degradation was noticed at the end of the reaction than at the beginning where the concentration 
of the compounds in mg/L range, and changed to g/L at the end of the kinetic experiments .  
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e)      f) 
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 i)          j) 
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k)   l) 
 
Figure 3.14: Effect of Initial Concentration of SMX, E2, BPA and HA in BPA- E2- SMX- HA mixture 
[SMX (a) UV/ H2O2, (b) UV/ O3 and (c) O3], [E2 (d)  UV/ H2O2, (e) UV/ O3 and (f) O3], [BPA (g) UV/ 
H2O2, (h) UV/ O3 and (i) O3] and [HA (j) UV/ H2O2, (k) UV/ O3 and (l) O3], the half concentration is the 
average of three samples  
 
3.3.3 Effect of Humic acid:  
 
 3.3.3.1 Effect of Humic acid on degradation rate constant of the model 
compounds: 
Humic acid is an assembly of heterogeneous complex organic species, such as polymerized 
organic acids, phenol, carbohydrates, amino acids and hydrocarbons (Black and Christman, 
1963), therefore it comprise sites that are involved in differing types of reactions which makes 
humic substances as radical initiators, promoters, as well as scavengers. The higher 
concentration of humic materials consumes the hydroxyl radicals – a scavenging effect which 
reduces the reaction rate (Staehelin and Hoigne, 1985)).  
 
a. Effect of humic acid on degradation rate constant of sulfamethoxazole: 
The effect of humic acid on degradation of SMX in the UV based AOPs is generally negative 
due to light absorption by the humic acid. As it was mentioned earlier that photolytic degradation 
rate of SMX is higher than by that of ozonation.  Therefore, the effect of humic acid on SMX 
degradation is more pronounced in the UV-based processes.  It is interesting to observe the rate 
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of degradation of SMX in ozonation increased in presence of HA as shown in Table 3.8, possibly 
due to the formation of reactive radicals.   However, this can’t be confirmed without knowing the 
mechanism of humic acid degradation by ozone.  The nonhomogeniety in the HA structure 
makes it more difficult to determine the exact mechanism of degradation.  
 
 Table 3.8: The effect of humic acid on the degradation rate constant, k (min
-1
) of 
sulfamethoxazole with O3, UV/ O3 and UV/ H2O2  
 
Chemical 
O3 UV/ O3 UV/ H2O2 
Rate constant 
k (min-1) 
Rate constant  
with HA 
 k (min-1) 
Rate constant 
k (min-1) 
Rate constant  
with HA 
 (min-1) 
Rate constant 
k (min-1) 
Rate constant  
with HA 
 kmin-1) 
SMX 
0.036 0.042 0.264 0.053 0.177 0.0015 
SMX- E2 
0.028 0.056 0.096 0.102 0.028 0.0004 
SMX- BPA 
0.043 0.135 0.143 0.08 0.029 0.046 
SMX- BPA- E2 
0.025 0.09 0.144 0.092 0.044 0.043 
 
 
b. Effect of Humic acid on degradation rate constant of 17-β estradiol: 
 
As for SMX, humic acid reduced the rate of degradation of E2 in UV based processes due to the 
competition for UV photons, and the effect was minimal for ozonation as shown in Table 3.9.  
Ozone decomposition is catalyzed by the humic substances at low concentration (Ma & Graham 
1999). Chowdhury et al (2010) observed that the rate of reaction of E2 was increased when the 
concentration of humic acid was elavated from 2-8 ppm, however due to the scavenging of 
reactive oxygen; the rate reached a plateau at 8 ppm as a result of increasing light attenuation 
with increasing humic acid concentration. 
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Table 3.9: The effect of humic acid on the degradation rate constant, k (min
-1
) of 17-β estradiol 
in different mixtures with UV/ H2O2, UV/ O3 and O3 
Chemical 
O3 UV/ O3 UV/ H2O2 
Rate constant 
k (min-1) 
Rate constant  
with HA 
 k (min-1) 
Rate constant 
k (min-1) 
Rate constant  
with HA 
 k (min-1) 
Rate constant 
K (min-1) 
Rate constant  
with HA 
 K (min-1) 
E2 ------ 0.021 ----- 0.062 ----- 0.0078 
E2- SMX 0.13 0.01 0.11 0.01 0.034 0.006 
E2- BPA 0.108 0.021 0.134 0.005 0.008 0.003 
E2- SMX- BPA 0.022 0.031 0.086 0.052 0.01 0.004 
 
 
c. Effect of humic acid on degradation rate constant of bisphenol A: 
The effect of humic acid on bisphenol A degradation was mixed as the rate increased in some of 
the mixtures while it was reduced in most of the experiments, especially in presence of 
UV/H2O2.  The effect was minimal for ozonation as shown in Table 3.10. 
 
Table 3.10: The effect of humic acid on the degradation rate constant, k (min
-1
) of bisphenol A 
in different mixtures after UV/ H2O2, UV/ O3 and O3 
 
Chemical 
O3 UV/ O3 UV/ H2O2 
Rate constant 
k (min-1) 
Rate constant  
with HA 
k  (min-1) 
Rate constant 
k (min-1) 
Rate constant  
with HA 
k (min-1) 
Rate constant 
k (min-1) 
Rate constant  
with HA 
k (min-1) 
BPA 0.085 0.078 0.082 0.164 0.011 0.002 
BPA-  E2 0.149 0.16 0.165 0.14 0.009 0.003 
BPA-  SMX 0.045 0.052 0.085 0.12 0.003 0.002 
BPA- E2- SMX  0.072 0.053 0.02 0.092 0.11 0.004 
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3.3.3.2 Effect of humic acid on the percentage of TOC removal 
(mineralization): 
The % of TOC removal was reduced when HA was added to all solutions in the three AOPs 
except in  BPA- SMX –E2 for all the AOPs. Refractory and complex intermediates are formed 
with the parent compounds, their intermediates and humic acid, which are hard to mineralize. In 
addition it was found that when the concentration was reduced by 50%, the TOC reduction was 
increased by 4%, 7% and 12% for UV/ H2O2, O3, and UV/ O3, respectively as shown in Figure 
3.15, 3.17 and 3.16.  
 
Figure 3.15: The effect of humic acid on the removal of TOC with UV/ H2O2 
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Figure 3. 16: The effect of humic acid on the removal of TOC with UV- O3 
 
 
Figure 3.17: The effect of humic acid on the removal of TOC with O3 
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3.3.4 Degree of Mineralisation using various AOPs: 
Mineralisation of the micropollutants is important to obtain a good water quality, however one of 
the challenges is to obtain a complete mineralization of these complex organic compounds which 
is determined by the total organic compound (TOC) of the solution. The TOC removal was 
measured in all three AOPs (UV/ H2O2, UV/ O3 and O3) applied in this work as shown in Table 
3.11.  
 
Table 3.11: Percentage of TOC removal after AOPs 
Chemical 
% TOC 
removal 
% TOC  
removal 
% TOC 
removal 
UV/ H2O2 UV/ O3 O3 
E2 25 38 29 
E2- HA 10 14 20 
BPA 28 73 49 
BPA- HA 5 18 31 
SMX 12 40 20 
SMX- HA 5 11 2 
E2- SMX 14 15 26 
E2- SMX- HA 1 3 6 
BPA- SMX 4.2 18.5 9.9 
BPA- SMX- HA 16.6 15.6 9.4 
E2- BPA 48.7 42.8 64.4 
E2- BPA- HA 8.4 20.0 16.5 
E2- BPA- SMX 4.6 6.0 4.5 
HA 5.7 13.2 18.8 
E2-BPA- SMX- HA 6.4 15.7 9.6 
0.5 E2-BPA- SMX- HA 10.0 28.8 16.4 
0.5 E2-BPA- SMX- HA 10.4 30.6 15.2 
0.5 E2-BPA- SMX- HA 10.5 24.8 18.0 
 
In most cases, ozonation and UV/ozonation performed the best for TOC reduction.  
It was observed a change in the color of the aqueous solution of different mixtures after UV/ 
H2O2, UV/ O3 and O3 treatments at different times of exposure as shown in Figure 3.18, which 
indicates the formation of new and different intermediates. The solutions that contain HA were 
clearer with time. In addition Figure 3.19 reveals different peaks of E2, SMX, and BPA and HA 
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compounds and their intermediates after AOPs treatments, this explains the incomplete removal 
of these micropollutants because of the formation of these refractory compounds.  
 
 a)         b) 
 
 
 c) 
 
3.18: Images of BPA E2 SMX mixture, samples taken in five different times (A) UV- O3 reactor (B) UV/ 
H2O2 reactor and (C) O3 reactor 
 
 
 
 
74 
 
a)       b) 
 
c)            d) 
 
e) 
 
Figure 3.19: HPLC chromatogram of different mixtures degradation: (a) HA BPA E2 SMX t=0 
min, (b) Half concentration of HA BPA E2 SMX with UV/ O3 t=10 min, (c) BPA E2 SMX with 
UV/ H2O2 BPA E2 SMX t= 20 min, (d) BPA E2 SMX with UV/ H2O2 BPA E2 SMX t= 50 min 
and (e) BPA E2 SMX with UV/ O3 BPA E2 SMX t= 10 min. IM (intermediate) 
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Chapter Four 
A comparative study of the effect of different advance oxidation 
processes on the estrogencity and genotoxicity of 17-β estradiol, 
Bisphenol A, Sulfamethoxazole, and Humic acid 
 
4.1 Introduction 
Earlier, the genotoxicity and estrogencity of several natural and synthetic organic compounds 
have been evaluated due to their potential adverse effect and the interference with the usual 
functioning of the endocrine system in humans and animals (Kaplan et al., 2004; Liehr 2000; Meier 
et al., 1986; Bridges et al., 1977; Chen et al., 2006; Aerni et al., 2004; Gagne & Blaise, 1998; Ikehata & 
El-Din, 2004; Bistan et al., 2011). Genotoxicity involves damage to the genetic material of the cell 
compounds including genetic damage to DNA, fixation of damage to DNA, and mutation by 
various mechanisms. The Ames test is used to detect the genotoxicity of the compounds such as 
typical genotoxins like aromatic amines that can cause mutation (Guidance for Industry, 2012), 
which can be defined as deleterious action on a cell's genetic material.  Several studies have been 
conducted to determine the genotoxicity of the micropollutants in water and wastewater (Crebelli 
et al., 1995; Shishida et al., 2000; Rizzo, 2011; Whatley & Cho, 2010). The mutagenic activity is 
determined by using the Ames test (Ames et al., 1975) using Salmonella typhimurium strains, 
carrying mutation(s) in the operon coding for histidine biosynthesis, that leads to the need of  
histidine for survival, but when the mutagen is present it will cause reverse mutation in which the 
bacteria will be able to survive without histidine. 
Endocrine disruptors compounds (EDCs) such as estrogens demonstrated altered sexual 
development such as feminization of male fish (Rodgers-Gray et al., 2000). The EDC 
compounds can be grouped as following (Caliman and Gavrilescu, 2009; Burkhardt-Holm, 
2010): 
1- Natural estrogenic/androgenic hormones: E2, E1, testosterone etc. 
2- Synthetic hormones: EE2, diethylstilbestrol, 19- norethindrone etc. 
3- Phyto- and mycoestrogens: daidzein, genistein, zear- alenone etc 
EE2 and E2 are the most potent estrogenic compounds, followed by E1 and E3 (Folmar et al., 
2002). Estrogenic activity is determined using the YES assay as described by Routledge and 
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Sumpter (1996), where a human estrogen receptor engineered with a beta-galactosidase and 
recombinant with Saccharomyces cerevisiae’s DNA is used. 
In the environment and aquatic system the estrogenic and non-estrogenic chemicals exist 
together as complex environmental samples not as a single compound. The non-estrogenic 
chemicals may mimic and/or interrupt the real estrogenic activity.  
Mixtures of chemicals are expected to induce greater biological effects (European Inland 
Fisheries Advisory Commission 1987; Frische et al., 2009; Thorpe et al., 2005). However, using 
mere summation of individual components to predict the cumulative behavior of mixture of 
compounds which called the concentration additive (CA) led to strongly confusing in-vitro 
observations (Silva et al., 2002; Frische et al., 2009; Thorpe et al., 2006). Hence, there are 
uncertainties if the CA can be a trustworthy method (Berenbaum, 1985; Greco et al., 1995) to 
evaluate the estrogenicity of mixtures.  
There are three significant major types of interference to estrogenicity (Frische et al. 2009): 
1- Toxic masking: Occurs if toxic chemical but non- estrogenic compounds are present in a 
mixture, it will cause reduction of the apparent estrogencity of both single estrogens and 
their mixtures due to the high toxic effect (Frische et al., 2009). 
 
2- Antagonistic modulation: It happens when a chemical confounder impairs the  estrogencity 
through decreasing the bioavailability of E2 (L. Chen et al. 2012) or  blocking membrane 
transport (Janosek et al. 2007). Tanghe et al. (1999) mentioned that humic acid causes 
reduction of bioavailability of the estrogenic compound.  
 
3- Synergistic modulation: This is a common phenomenon in aquatic biotests where some non-
estrogenic chemicals can increase the apparent estrogenic activity. In addition, the weak 
xenoestrogens are able to create an impact upon strong estrogens (Rajapakse, N., et al., 
2001), and the bioavailability of E2 was increased by low concentrations of humic acid (L. 
Chen et al. 2012), furthermore changing the permeability of biological membranes 
(Vigneault et al. 2000). 
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 While the removal of estrogens and the genotoxins in wastewater treatment plant is incomplete, 
some transformation processes may produce more harmful by-products or transformation 
products. (Bila et al., 2007; Nakamura et al., 2006; Shappell et al., 2008). During tertiary 
treatment using UV based advanced oxidation processes are able to reduce the concentration of 
micropollutants in wastewater effluents to some extent.  However, intermediates formed during 
treatment may have higher toxicity; for example, UV/H2O2 was found to increase mutagenicity 
of water sample (Heringa et al. 2011).  On the other hand, some studies  have demonstrated the 
efficiency of AOPs  to reduce estrogencity and/or the genotoxicity after ozonation,  (Beltrán et 
al. 2008; Esplugas et al., 2007; Gunten, 2003),  UV, UV/O3 or H2O2, and TiO2 (Irmak, Erbatur, 
and Akgerman 2005; P.-J. Chen et al. 2007; Bolton, Linden, and Asce 2003). However, the 
effects are very system and compound specific.  The background water quality such as the effect 
of dissolved organic compounds also can be very different for different compounds.  
In this study four compounds of increasing concern, sulfamethoxazole an antibiotic, estrogenic 
compound 17-β estradiol, and industrial chemical BPA, which is also an endocrine disrupting 
compound (EDC), and humic acid (NOM) have been used as model compounds. The estrogenic 
activity is determined by the yeast estrogencity screen (YES) assay, and the genotoxicity is 
monitored by using the Ames test, before and after three different three advanced oxidation 
processes UV/H2O2, UV/O3 and O3. The effects of different concentrations and mixtures of the 
model compounds, oxidant type, and background water quality have been studied.  
 
4.2 Experimental  
4.2.1 Chemicals: 
17-β estradiol (chemical formula: C18H24O2, CAS: 50-28-2) was obtained from Sigma- Aldrich 
(Oakville, Ontario, Canada) of 98% purity. Sulfamethoxazole (chemical formula: C10H11N3O3S, 
CAS: 723-46-6) was obtained from Fluka Analytical, bisphenol A (chemical formula: C15H16O2, 
CAS: 80-05-7) was obtained from Sigma–Aldrich (Oakville, Ontario, Canada) of 99+% purity, 
and humic acid (Average chemical formula C187H186O89N9S1, CAS: 1415-93-6) was obtained 
from Alfa Aesar.  
 
 
84 
 
All reagents were used as received without further purification. Laboratory-grade Ultrapure 
(MiliQ) water (conductivity of 18M Ω) was obtained  from a Millipore purification system 
(model Integral 5, EMD Millipore Corporation, Billerica, MA, USA).  
 
4.2.1.1 Chemicals for the YES assay: 
 
Minimal Medium:  
 
Contaminated glassware, spatulas, stirring bars, etc. with an estrogenic chemical will lead to 
elevated background expression; therefore, they were scrupulously cleaned, and had no prior 
contact with steroids. The glassware, spatulas and stirring bars were rinsed twice with absolute 
ethanol, and left to dry.  
The following chemicals, shown in Table 4-1, were added to prepare minimal growth media. All  
 
Table 4.1: List of chemicals for minimal media preparation for the YES assay 
Chemical Amount Supplier/ Location Purity 
KH2PO4  13.61 g    Caledon/ Canada                           -----           
(NH4)2SO4  1.98 g    Caledon/ Canada                           ----- 
MgSO4  0.2 g    Caledon/ Canada                           ----- 
Fe2(SO4)3  1ml of  
(40 mg/50 ml 
H2O) solution  
  Alfa Aesar/ Canada                       ----- 
L-Ieucine  50 mg   Alfa Aesar/ Canada  99% 
L-histidine  50 mg   Alfa Aesar/ Canada  98% 
Adenine  50 mg   Alfa Aesar/ Canada  99% 
L-arginine-H  20 mg   Alfa Aesar/ Canada  98% 
L-methionine  20 mg   Alfa Aesar/ Canada  98+% 
L-tyrosine  30 mg   Alfa Aesar/ Canada  99% 
L-isoleucine  30 mg   Calbiocheem/ Canada  99% 
L-lysine-HCI,  30 mg   Calbiocheem/ Canada  99.6% 
L-phenylalanine  25 mg   Alfa Aesar/ Canada  99% 
L-glutamic acid  100 mg   Alfa Aesar/ Canada  99% 
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the chemicals were dissolved separately in Milli-Q water and stirred on a hot plate. 
KOH pellets were dissolved in 5 ml Milli-Q water and added gradually to the above mixture of 
chemicals to obtain a pH of 7.0 (± 0.1). The final volume of the solution was adjusted to 1 L 
using Milli-Q water. The media was sterilized at 121°C for 10 min to avoid any bacterial 
contamination. Thereupon, it was stored in glass bottles at room temperature.  
 
Chemicals for preparation of yeast for assay: 
 
The  growth medium was prepared by adding 5 ml glucose solution, 1.25 ml L-aspartic acid 
solution, 0.5 ml vitamin solution, 0.4 ml L-threonine solution, and 125 ul copper (II) sulfate 
solution to 45 ml minimal medium. Then, it was transferred to a sterile conical flask (final 
volume of approximately 50 ml). A 125 µl of 10X concentrated yeast stock from cryogenic vial 
was added and incubated at 28°C on an orbital shaker for approximately 24 hours or until turbid.  
D-(+)-Glucose (Alfa Aesar, CA) A 20% w/v solution was prepared and sterilized in 20 ml 
aliquots at 121°C for 10 min in distilled water.  
L-Aspartic Acid (Alfa Aesar, CA) - A stock solution of 4 mg/ml of aspartic acid was prepared 
in distilled water and sterilized in 20 ml aliquots at 121°C for 10 min.  
 
Vitamin solution was prepared by adding 8 mg thiamine, 8 mg pyridoxine (Sigma Aldrich, 
USA, 8 mg pantothenic acid (98%, Alfa Aesar, Canada), 40 mg inositol (Himedia/ India), and 20 
ml biotin solution (2 mg/100 ml H2O) (Fluka, USA) to 180 ml 71 double-distilled water. The 
solution was sterilized by filtering through a 0.2 µm pore size disposable filter (VWR 
international, CA) into sterile glass bottles and stored at 4 °C for further use.  
 
L-Threonine (Alfa Aesar, CA) solution of 24 mg/ml was prepared in distilled water. The 
solution was sterilized at 121°C for 10 min and stored at 4 °C prior to use.  
 
Copper (II) Sulfate (VWR BDH Prolabo) solution of 20 mM was prepared in distilled water. 
The solution was sterilized by filtering through a 0.2 µm pore size filter (Cellulose acetate, 
VWR, CA) in sterile glass bottles in 5 ml aliquots and stored at room temperature.  
 
Chlorophenol red-β-D-galactopyranoside (CPRG) (Sigma- Aldrich) – a 10 mg/ml stock 
solution of CPRG was prepared in distilled water. It was further sterilized by filtering through a 
0.2 µm pore size filter (Cellulose acetate, VWR, CA) into sterile glass bottles in a laminar flow 
cabinet and stored at 4 °C. 
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4.2.1.2 Chemicals for the Ames: 
Standard Mutagens:  
9-Aminoacridine (Alfa Aesar, Canada) and Sodium azide (Caledon/ Canada). 
 
Concentrate Davis-Mingioli salts consist of 38.5 g of dipotassium phosphate (Caledon/ 
Canada), 11 g of monopotassium phosphate (Caledon/ Canada), 2.75 g of sodium citrate 
(Caledon/ Canada), 0.55 g magnesium sulphate (Caledon/ Canada) and 5.5 g of ammonium 
sulphate (Caledon/ Canada).  
 
Reaction Mixture (RXM) consists of  Davis-Mingioli salts (concentrate) 43.24 ml, 9.5 ml of 
40% D-glucose (Alfa Aesar, Canada),  4.76 ml of 2 mg/L Bromocresol Purple (Caledon/ 
Canada), 2.38 ml of 0.1 mg/L D-Biotin (Sigma Aldrich/ Canada and 0.12 ml of 0.1 mg/L 
Histidine (Alfa Aesar / Canada).  
4.2.2 The toxicity experiment of sulfamethoxazole (SMX) for the 
Saccharomyces cerevisiae and the Salmonella typhimurium TA 97 and 
TA 100:  
The toxicity experiment of sulfamethoxazole (SMX) for the yeast of the YES assay 
(Saccharomyces cerevisiae) was performed by diluting 100 ppm and 80 ppm of SMX using a 
twofold serial dilution, then 100 µL of each dilution  was added to 100 µL of the yeast. The dose 
effect of SMX was monitored after 24 hrs of incubation at 30 
o 
C by measuring the growth of the 
yeast at absorbance 540 nm. Two rows of each concentration were used in addition to a three 
rows of the positive control which contain the 100 µL of the yeast plus 100 µL of milli-Q water. 
Two rows of the negative control were prepared by adding 100 µL of the yeast, 10 µL of ethanol 
and 90 µL of milli-Q water.  
 
4.2.3 A comparison between the YES assay with GCMS analysis: 
 
The comparison between 17-β estradiol (E2) equivalents (EEQs) in the YES assay versus the 
actual concentrations measured by the GCMS was done. These tests were conducted with known 
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concentration of E2 dissolved in methanol and then diluted in mili-Q water in the concentration 
range of E2 at 5-50 μg/L.  
 
4.2.4 Yeast Estrogen Screen: 
 
Estrogenic activity was determined using the YES assay as described by Routledge and Sumpter 
(1996). A recombinant yeast strain (Saccharomyces cerevisiase) was obtained from Trojan UV 
(Ontario, Canada). A 250 μL concentrated yeast stock from cryogenic vial was added to the 
conical flask containing the growth medium. The flask was incubated at 28°C, 180 rpm for 
approximately 24 hours or until turbid with an optical density of ~1 on an orbital shaker. A 
standard solution (50 μg/L) was prepared using 17-β estradiol (E2) and was diluted using a 
twofold serial dilution in absolute methanol; 12 dilutions in the range of 24.41 ng/L - 50,000 
ng/L of E2 were prepared. For standard tests, 10 μL of the E2 standard dilutions were added to 
three rows of wells in a 96-microtitre plate (Corning Costar, USA) and allowed to dry 
completely. The blank was prepared by adding 10 μL of absolute methanol to 190 μL of the 
assay media (growth medium containing the dye, chlorophenol red-β-D-galactopyranosid 
(CPRG), and yeast) to two rows of the same 96-microtitre plate. The samples were treated 
differently depending on the micropollutants type. For the preliminary study of BPA, samples of 
10 mL from each AOP reactor were collected and freeze-dried overnight and re-dissolved in 1 
mL of methanol with a recovery of 87-100%. Thereafter, 60 μL of the concentrated samples 
were further two-fold serially diluted in two rows of the 96-microtitre plate using methanol, and 
were left to fully evaporate. Subsequently, 200 μL of the seeded assay medium was added to 
each well. Due to the high cost of the freeze drying, the rest of pure BPA and BPA mixtures 
were used by adding 10 times of the regular amount of sample (100 μL) to a 100 μL of 10 times 
concentrated assay media. Two rows of the sample were prepared in 96-microtitre plate by using 
twofold serial dilution with Milli-Q water. For the rest of the samples two rows of each sample 
were prepared by diluting the sample with Milli-Q water using a two-fold serial dilution in the 
96-microtitre plate.  Thereafter, 10 μL of each dilution was transferred to the assay plate in 
which 190 μL of the assay media was added. 
The plates were sealed with sterile adhesive film and shaken vigorously for 2 min in a plate 
shaker (VWR). Subsequently, the plates were incubated at 30°C in a naturally ventilated heating 
cabinet for 3 days. After the incubation, the plates were shaken at 240 rpm for 2 min, and left for 
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approximately 1 hour to allow the yeast to settle. The YES assay was done in duplicate for the 
samples and the blank, and in triplicate for E2 standard. A typical dose-response curve for E2 is 
shown in Fig. 4.1.  
 
Figure 4.1: The log concentration of 17β estradiol serially diluted from 24.41ng/L - 50,000 ng/L 
versus the absorbance after three days of incubation. The diamonds are the average of standard 
triplicates, and the line is the best fits using the Hill equation 
 
The absorbance of the sample, standard and blanks were read at an absorbance of 540 nm (optimum 
absorbance for CPRG 575 nm) and 620 nm (for turbidity) using a plate reader (Infinite® 200 PRO, 
Tecan, USA) as shown in schematic of Figure 4.2.  
 
YES assay calculations: 
 
The absorbance data at 540 nm was used to evaluate the response of the yeast strain. A control 
experiment with known estrogen concentration was run with each plate. Plotting the response at 
540 nm vs. the E2 concentration results in a sigmoidal plot. The resulting sigmoidal dose-
response curve was analyzed using the Hill equation (4.1) following the method described by 
Huber (2004).  
        
   
  (
   
    
⁄ )
    ………………………………………………………………... (4.1) 
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where OD540 is the optical density at 540 nm, XE2 is the E2 concentration [mg/L] and  a, b, m and 
EC50 are fitting parameters representing the low response, high response, Hill-slope, and the half 
maximal effective concentration [mg/L]. 
The parameters were estimated using nonlinear regression analysis implemented in Matlab 
(Matlab 2013b MathWorks, Natick, MA), see Appendix (6.1) for code. Experimental dataset 
with an unknown amount of estrogenic compounds(s) were analyzed with a modified Hill 
equation (4.2): 
         
   
  (     ⁄
)
    …………..……………………………………………………... (4.2) 
Where D is the dilution factor of the original sample [-] (dilution in the well) resulting in a 
dimension of EC50. The estrogen equivalent concentration (EEq) [mg/L] can be estimated as the 
ratio of the sample’s EC50 and the standard’s EC50 equation (4.3): 
           
    
               
    
      
    
 …………………………………………………………...... (4.3) 
 
 
 
Figure 4.2: The schematic of the YES assay 
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4.2.5 The Ames test: 
The mutagenic activity and mutagenic material in water samples were determined by using the 
Ames test (Ames et al., 1975). Reverse-mutation assays have been performed using the 
`Fluctuation test' originally devised by Luria and Delbruck (1943) and modified by Hubbard et 
al. (1984). In this test two strains of Salmonella typhimurium TA97a and Salmonella 
typhimurium TA100 (obtained from EBPI- Environmental bio- detection product inc.) were 
used. They carry mutation(s) in the operon coding for histidine biosynthesis. Standard mutagens 
9-aminoacridine (0.4 mg/ml) was used for S. typhimurium TA97a and sodium azide (0.1mg/ml) 
was used for S. typhimurium TA100.  
A sample of 5 ml was filtered through 0.22 µm membrane PTFE filter. Then it was mixed with 
2.5 ml of the reaction mixture RxM (Davis-Mingioli salts, D-glucose, Bromocresol Purple, D-
Biotin and L-Histidine), 12.5 ml of distilled water, and 10 µl of the bacteria with an optical 
density of 0.5 \. The positive control was prepared by adding 0.1 ml of the standard mutagen to 
2.5 ml of the RxM, 17.4 ml distilled water and 10 µl of the bacteria. The background was 
prepared by adding 17.5 ml distilled water to 2.5 ml of the RxM and 10 µl of the bacteria. The 
blank (the sterility check) was prepared by adding 17.5 ml distilled water to 2.5 ml of the RxM 
only.  
Afterward 200 µl of the mixtures was dispensed into 96-well micro-titration plate (Corning 
Costar, USA). The plates were covered with a lid and put into a plastic bag to prevent 
evaporation, then transferred to a 37°C incubator for five days. 
 
 Analysis of the Ames results: 
The response of Ames test to BPA, E2, and SMX and HA as pure compounds and mixtures after 
different oxidation times, by using two Salmonella strains was determined visually. After five 
days of incubation at 37°C the number of positive reaction was monitored by changing  the color 
from purple to yellow as a positive reaction as shown in Figure 4.3. The `Background' showed 
the level of spontaneous or background mutation of the assay organism. The results for each 
treatment plate refers to positive responses in the sample plate vs. positive responses in the 
background plate, and the number of positive wells scored in a 96-well microtitre plate leading to 
clear significance in the fluctuation test by using Table 4.2. 
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Figure 4.3: The Ames plates showing the reverse mutation 
 
 
Table 4.2: The number of positive wells scored in a 96- well microplate leading to clear 
significance (The Muta-ChromoPlateTM Bacterial Strain Kit, Version 3.3, 2009) 
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The number of positive wells scored in a 96- well microplate leading to clear significance 
 
 
4.3 Results and Discussions: 
4.3.1 Preliminary studies for estrogencity, toxicity and mutagenicity of model 
compounds: 
 
4.3.1.1 Toxicity experiment of sulfamethoxazole (SMX) for Saccharomyces 
cerevisiae and Salmonella typhimurium TA 97 and TA 100:  
Sulfamethoxazole (SMX) being an antibiotic, toxicity of SMX for the yeast used in the YES 
assay (Saccharomyces cerevisiae) was evaluated by using two fold serial dilutions of 100 ppm 
and 80 ppm SMX.  Optical density measurements after 24 hrs of incubation at 30 
o 
C by (540 
nm), showed that SMX did not affect the growth of the yeast. 
 
 
93 
 
Similar toxicity experiment was conducted with the bacteria of the Ames test (Salmonella TA 97 
and TA 100). Optical density measurements after 24 hrs of incubation at 37 
o 
C by using the 
reader at 600 nm showed that SMX did not affect the growth of the S. typhimurium TA 97 and 
TA 100. The toxicity tests are summarized in the diagram shown in Figure 4.4. 
 
 
 
Figure 4.4: Toxicity experiment of sulfamethoxazole for yeast of the YES assay and the bacteria 
of the Ames test 
 
4.3.1.2 YES assay vs GCMS analysis: 
 
The 17-β estradiol (E2) equivalents (EEQs) of known E2 concentrations were measured via the 
YES assay and compared to what was measured via GCMS. These tests were conducted with 
known concentration of E2 dissolved in methanol and then diluted in mili-Q water in the 
concentration range of 5 μg/L-50 μg/L. There is a linear relationship between the EEQ and the 
GCMS response with the original concentration as shown in Figure 4.5, and the EEQs are always 
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within 80% of the original concentration. The purpose of this quality control study was to ensure 
that the sample preparation was not introducing a bias or rendering the assay non-suitable for the 
desired concentration range.  
 
 
 
Figure 4.5: Comparison of YES assay with the GC-MS analysis  
(GCMS data were the average of two samples) 
 
4.3.1.3 The estrogencity and the mutagenicity of different concentrations of 
the model compounds: 
The results of the Ames test for 17-β estradiol, bisphenol A, sulfamethoxazole, and humic acid 
by using different concentrations showed some reverse mutation of Sallmonella TA 97 and 
Sallmonella  TA 100: however, none of them were statistically significant as  shown Table 4.3. 
The existing literature shows contradictory results on the mutagenicity of SMX. Isidori et al. 
(2005) mentioned that SMX is mutagenic, on the other hand Nakmura et al. (1995), found that 
SMX didn’t show mutagenicity to Sal. strain TA 98 and TA 100. Humic acid is not mutagenic 
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by itself; however, it can result in mutagenic actions detected by the Ames test after chlorination 
(Meier et al. 1986). 
17-β estradiol is not mutagenic; although Lieher (2000) mentioned that E2 is a weak carcinogen 
and a weak mutagen. Bisphenol A is not mutagenic and this agrees with the result of Ike et al. 
(2002).  
The results of the YES assay for 17-β estradiol showed a strong estrogencity as E2 has the 
highest estrogenic potential amongst the natural estrogens (Routledge & Sumpter 1997). 
Bisphenol A showed weak estrogencity as it is considered as a weak estrogen known as 
xenoestrogens (Rajapakse et al. 2002; Ike et al. 2002). SMX exhibited no estrogencity and this 
agrees with (Esaher, et al. 2005).  Humic acid by itself had shown no estrogencity as presented in 
Table 4.3.  
4.3.2 The estrogencity of 17-β estradiol, Bisphenol A, Sulfamethoxazole, and 
Humic acid: Effect of different AOPs: 
 
In this chapter, the estrogenic activity was determined using the YES assay as described by 
Routledge and Sumpter (1996). This assay is based on a DNA recombinant strain of the yeast 
Saccharomyces cerevisiae, as shown in Figure 4.6 a, which contains a gene for the human 
estrogen receptor hER and expression plasmids, which is encoding  the enzyme  β-galactosidase 
that results in changing the color of  chlorophenol red-β-d-galactopyranoside (CPRG) from 
yellow to red, as shown in Figure 4.6 b. 
                             
Figure 4.6 a) Saccharomyces cerevisiae X100 b) Assay plate showing the change in the color from 
yellow to pink as a response of the yeast screen to 12 dilutions of the standard E2 in the range 24.41 ng/L- 
50,000 ng/L (row F,G and H) and the samples (row A, B, C, D and E) 
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Table 4.3: The estrogencity and the mutagenicity of the model compounds 
Compound 
(mg/L) 
Mutagenicity in 
the Ames test 
(EEQ mg/L) in the  
YES assay  
BPA Non mutagenic Estrogenic 
100 - 0.00437 
50 - 0.00183 
25 - 0.00064 
11.6 - 0.00049 
5 - 6.21E-23 
1 - 4.54E-25 
E2 Non mutagenic Estrogenic 
50 - 50 
25 - 22.8 
12.5 - 10.5 
6.25 - 6.69 
3.125 - 3.5 
1 - 0.93 
SMX Non mutagenic Non estrogenic 
100   
50 - - 
25 - - 
12.5 - - 
6.25 - - 
3.125 - - 
1 - - 
HA Non mutagenic Non estrogenic 
1000 - - 
500 - - 
750 - - 
250 - - 
 
 
The estrogencity of 17-β estradiol (C0 = 0.7 mg/L), bisphenol A (C0 = 11.6 mg/L), 
sulfamethoxazole (C0 = 0.7 mg/L), and humic acid (C0 = 1000 mg/L) was measured as pure 
compounds as well in mixture by calculating the estrogenic equivalent concentration (EEQ) see 
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Appendix (6.2) for all the mixtures of these micropollutants after the exposure time to three 
advance oxidation processes (O3, UV/O3 and UV/H2O2) as shown in Figure 4.7. 
 
 
 
Figure 4.7: The schematic of the experimental procedure  
4.3.2.1 The estrogencity of pure 17-β estradiol with exposure to advance 
oxidation processes: 
UV/O3 led to reduce the estrogencity by 100% after only 10 min of treatments as shown in 
Figure 4.8 b and Figure 4.10. This result is in line with the chemical analysis by HPLC which 
showed fast degradation of E2 after 10 min of treatment. O3  and UV/ H2O2  showed ~ 100% of 
measured EEQ after 50 min of treatment as shown in Figure 4.8 a. and c. 4. 8, Figure 4.9 and 
Figure 9.11. 
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    a)          b) 
 
c) 
 
Figure 4.8: The EEQ of E2 C0 = 0.7 mg/L and pH= 6.4 after different AOPs (a) O3 (b) UV/ O3, (c) UV/ 
H2O2 (x) sample number one and two  
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Figure 4.9: Reduction in the estrogencity of E2 C0 = 0.7 mg/L and pH= 6.4 after different 
treatment times with ozone; Ozone dosage is 1.31 mg/L. (x) sample number one, (o) sample 
number two 
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Figure 4.10: Reduction in the estrogencity of E2 C0 = 0.7 mg/L and pH= 6.4 after different 
treatment times with UV- O3; UV- intensity on the quartz surface was measured to be 18 
mW/cm
2
, Ozone dosage is 1.31 mg/L, (x) sample number one, (o) sample number two 
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Figure 4.11: Reduction in the estrogencity of E2 C0 = 0.7 mg/L and pH= 6.4 after different 
treatment times with UV- H2O2; UV- intensity on the quartz surface was measured to be 18 
mW/cm
2
, H2O2 dosage is 10 mg/L, (x) sample number one, (o) sample number two 
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4.3.2.2 The estrogencity of pure and mixtures of sulfamethoxazole, and humic 
acid with exposure to advance oxidation processes: 
Sulfamethoxazole showed no estrogencity in all three AOPs as shown in Figure 4.12. This result 
is in line with (Esaheret al. 2005). Humic acid also showed  no estrogencity  as it binds to the 
estrogen receptor and blocks the access for estrogenic compounds (Tanghe, Tom; Devriese, 
Greet; Willy 1999) as shown in Figure 4.13. The combination of SMX and HA showed no 
estrogencity after different AOPs treatment times as shown in Figure 4.14.  
 
 
Figure 4.12: SMX C0 = 80 mg/L and pH = 5.2 showed no estrogencity in all AOPs (x) sample 
number one, (o) sample number two 
 
 
Figure 4.13: HA C0 = 1000 mg/L and pH = 6.2 showed no estrogencity in all AOPs (x) sample 
number one, (o) sample number two 
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Figure 4.14: SMX and HA mixture showed no estrogencity in all the AOPs, SMX C0 = 80 mg/L 
and pH= 5.2, HA C0 = 100 mg/L and pH= 6.2 (x) sample number one, (o) sample number two 
 
4.3.2.3 The synergistic or antagonistic effect of non-estrogenic compounds on 
the estrogencity of 17-β estradiol: 
 
As mentioned earlier SMX is not estrogenic: however, in our study it was found that SMX has a 
synergistic interaction with E2 which led to increase in the measured EEQ by 2.7 times. In 
addition, it took longer to reduce the estrogencity of SMX and E2 mixture by all the AOPs.  For 
example E2- SMX mixture showed  ~ 71% drop in estrogencity in UV/H2O2 after 90 min of exposure 
while pure E2  showed ~ 100%  reduction of EEQ after 50 min of UV/H2O2 treatment.  
Ozone showed ~ 98% reduction in estrogencity after 90 min of treatment for E2- SMX mixture as 
shown in Figure 4.15 a. However, pure E2 had ~ 100% reduction in EEQ after 50 min of 
treatment. While UV/O3 showed ~ 100% reduction in estrogencity after 90 min of treatments for 
E2- SMX mixture as showed in Figure 4.15 b. However, pure E2 gave ~ 100% of reduction 
measured EEQ after 10 min of treatment. 
 
Of all the AOPs tested UV/O3 had the best performance in the removal of estrogenicity both for 
pure E2 and the mixture of E2 and SMX.  
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     a)               b) 
 
 
 
 
Figure 4.15: The EEQ of E2 and SMX mixture after (a) O3 (b) UV/O3 (c) UV/ H2O2, SMX C0 = 
80 mg/L and pH= 5.2, E2 C0 = 0.7 mg/L and pH= 6.4, (x) sample number one and two 
 
Humic acid also showed a synergistic effect on the estrogencity of E2 which led to increase the 
measured EEQ by 4.4 times, and also it affected the percentage of reduction. As E2-HA mixture 
gave ~ 98%, 99%, 61% of reduction in the measured EEQ for O3, UV/O3 and UV/H2O2, 
respectively after 90 min of treatments whereas it took only 10-15 minutes of AOP treatment for 
pure E2.  UV/H2O2  treatment was the least effective of the three AOPs tested as it took longer to 
reduce the estrogencity.  Since very high concentration of humic acid (1000 mg/L) was used in 
the experiment, adsorption of relatively hydrophobic E2 to carbon-rich HS seems to be 
insignificant, as shown in Figure 4.16 a, b and c.  
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  a)          b) 
 
c) 
 
Figure 4.16: The EEQ of E2 and HA mixture after (a) O3 (b) UV/ O3, and (c) UV/ H2O2, E2 C0 = 
0.7 mg/L and pH= 6.4, HA C0 = 1000 mg/L and pH= 6.2, (x) sample number one and two  
 
4.3.2.4 The synergistic effect of xenoestrogens compound on the estrogencity 
of 17-β estradiol: 
 
There was no concentration addition of the EEQ of BPA and E2 when they were mixed together; 
rather a synergistic interaction between the strong estrogen E2 and a weak xenoestrogen BPA 
was observed. BPA and E2 mixture showed ~ 100% reduction in the EEQ after 50 min and 20 
min for O3 and UV/O3 treatment,  respectively, as shown in Figure 4.17 a and b. While UV/ H2O2 
showed only ~ 71% reduction after 90 min of treatment as shown in Figure 4.17 c. Rajapakse et 
al. (2002) and Silva et al (2002) reported that xenoestrogens are able to act together when 
combined at concentrations below their no-observed-effect concentration (NOECs) to produce 
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significant effects. Bliss (1939) mentioned that when the compound is present at the sub 
threshold doses the individual compound is not assumed to contribute to the overall mixture. It 
was found that the removal rates of in vitro estrogenic activity of the EDC mixtures were lower 
than that observed for single compounds for E2 and BPA and in a mixture with 17α-
ethinyl estradiol (EE2) and nonylphenol  (NP) (Chen et al. 2007). As for the other cases, 
UV/H2O2 treatment took longer compared to simple ozonation and UV/O3 process.  
 
  
        a)     b) 
 
                                                                    
c) 
 
Figure 4.17: The EEQ of E2 and BPA mixture after (a) O3 (b) UV/ O3, and (c) UV/ H2O2, E2 C0 
= 0.7 mg/L and pH= 6.4, BPA C0 = 11.6 mg/L and pH= 6, (x) sample number one and two  
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4.3.2.5 The synergistic - antagonistic interaction of SMX BPA HA mixture on 
the estrogencity of 17-β estradiol: 
 
It was found that SMX BPA HA E2 mixture gave a ~ 98 % and ~ 99 % reduction after 90 min of 
treatments in O3 and UV/O3 as shown in Figure 4.18 a and b, respectively. However, UV/H2O2 
showed only ~ 11% reduction after 20 min of exposure as shown in Figure 4.18 c. Then it 
showed an increase in the measured EEQ by ~ 50 % and 25 % comparing with the original value 
after 50 min and 90 min, of time, respectively. All this indicates intermediate formation that is 
more estrogenic than the parent compound.  This warrants further chemical and biassays to 
confirm this result.   
 
     a)         b) 
 
c) 
 
Figure 4.18: The EEQ of E2, BPA, and SMX and HA mixture after (a) O3 (b) UV/ O3, and (c) 
UV/ H2O2, E2 C0 = 0.7 mg/L and pH= 6.4, BPA C0 = 11.6 mg/L and pH= 6, (x) sample number 
one and two  
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     4.3.2.6 The antagonistic-synergistic interactions of different mixtures on the 
estrogencity of 17-β estradiol: 
 
As mentioned earlier, although SMX and humic acid are non-estrogenic compounds; they have a 
synergistic effect on the estrogencity of E2. HA showed synergistic effect on E2 by increasing 
the EEQ by 4.4 times, when it was in a mixture with E2. While the addition of  SMX showed a 
lower synergistic effect than HA on the estrogencity of E2 by increasing the EEQ 2.7 times as 
shown in Table 4.4 and Figure 4.19. The combination of E2 SMX and HA gave the highest 
synergistic effect; a 4.7 times increase in the EEQ of E2. Chen et al. (2012) & Steinberg et al. 
(2006) showed that the bioavailability of E2 was increased in the presence of humic acid. 
Vigneault et al. (2000) mentioned that HA can cause some change in the permeability of 
biological membranes which could increase the uptake of E2. It is possible that the blocking and 
inhibition of the modification of multixenobiotic resistance transporter (MXR) activity by direct 
interaction of DOM with organisms can cause intracellular accumulation of E2 and lead to the 
increase in estrogenic effects of E2, this could also  increase the bioconcentration (Chen et al. 
2012). 
The relative contribution of different compounds on the estrogenicty of E2 was quantified using 
factorial fit. Of all the different combinations, BPA E2 mixture showed a 2.4 times increase of 
the EEQ than pure E2 .Thorpe et al. (2003) reported that E2 and BPA when present in a mixture 
are each able to contribute to the overall effect of the mixture, producing a mixture that is more 
potent than either of the individual chemicals. E2- BPA- SMX- HA mixture showed 3.4 times 
increase in the EEQ. The synergistic effect of different compounds with E2 is rather complex 
and is never additive.  Therefore, it may never be possible to estimate the estrogenicity of a 
mixture a-priori, but YES assay is a powerful tool to determine estrogenicity of a mixture 
quantitatively without knowing the complex molecular and bio-chemistry.  Silva, et al. (2002) 
mentioned that there is a large difference between the additive estrogenicity by simple 
concentration addition and independent action (IA) which means that compounds may work on 
different systems within the organisms (Bliss, 1939). However, Chen, et al., (2007) reported that 
the estrogenic activity was additive.  
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Table 4.4: The EEQ of different mixtures of E2 
 
Sample ID 
EEQ 
[mg/L] 
±Error 
[mg/L] 
 
Increase 
X 
Reduction 
X 
E2 0.7 0.1  ---- ---- 
E2+ HA 3.1 2.1  4.4 ---- 
E2 SMX 1.9 0.2  2.7 ---- 
E2 SMX HA 3.3 0.7  4.7 ---- 
E2BPA  1.7 0.7  2.4 ---- 
E2 BPA HA 0.2 0.3  ---- 3.5 
E2 BPA SMX 0.2 0.1  ---- 3.5 
E2 BPA SMX HA 2.4 0.8  3.4 ---- 
0.5 E2 BPA SMX 
HA 
0.5 0.7  ---- 1.4 
HA n.d n.d    
BPA n.d n.d    
SMX  n.d n.d    
SMX HA n.d n.d    
BPA HA n.d n.d    
BPA SMX n.d n.d    
BPA SMX HA n.d n.d    
 
n.d = not detected  
 
Humic acid can have a masking response of to the estrogenic compound causing low 
bioavalibility (Tanghe et al. 1999).  Membrane transport blockage of gonadotropic hormone, and 
changes of membrane permeability of E2 can be the reason of antiestrogenic effects (Janosek et 
al. 2007).  
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Figure 4.19: The EEQ of different mixture of E2 C0 = 0.7 mg/L and/ or SMX C0 = 80 mg/L, 
and/ or BPA C0 = 11.6 mg/L and/ or HA C0 = 1000 mg/L comparing with pure E2, (x) sample 
number one, (o) sample number two 
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4.3.3 The mutagenicity of 17-β estradiol, Bisphenol A, Sulfamethoxazole, and 
Humic acid: Effect of different AOPs: 
 
The results of the Ames test for pure 17-β estradiol, bisphenol A, sulfamethoxazole, and humic 
acid and their mixtures after different exposure times of three advance oxidation treatments (O3, 
UV/O3 and UV/H2O2) showed no mutagenicity. Some reverse mutations were observed with 
Salmonella typhimurium TA 98 and TA 100, especially for the UV/H2O2 treatment; however, 
none of them were statistically significant as shown in Figure 4.20 and 4.21. 
In a study of the SMX mutagenicity using the Ames spot test with two strains of Salmonella 
typhimurium TA 98 and TA 100, the results were expressed as revertants/µg of antibiotic by 
analyzing linear regression of the dose–response curves of the samples, which found to be 
mutagenic (APHA, 1998). In another study done by Dantas et al. (2008), it was found that SMX 
produced statistically significant increases (P≤0.05) in mutant frequency. 
On the other hand, Nakmuraet al. (1995) performed the Ames spot test; it was found that SMX 
didn’t show mutagenicity to Sal. strain TA 98 and TA 100. However, N-acetoxy-SMX showed 
dose-dependent mutagenicity for Sal. TA100. Sulphamethoxazole can form a photodegradation 
product in aqueous solution by several pathways (Moore, 1998) sometimes forming more 
harmful byproducts than parent compound (DellaGreca et al., 2003). In addition, it can cause 
cytotoxic or cytostatic effects in human cells (Abou- Eisha= et al., 2004). However, in these 
experiments SMX was never mutagenic using any of the advanced oxidation processes.   
E2 didn’t show mutagenicity in the Ames test, except 16OHE1 is the only estrogen that has been 
shown to be mutagenic in the Ames test (“Estrogen Metabolism,” 2007). On the other hand, 
Liehr (2000) showed that E2 is a weak carcinogen and a weak mutagen capable of inducing 
genetic lesions with low frequency. However, the catechol estrogens failed to be mutagenic in 
the Ames test (Liehr et al., 1986). Humic acid is not mutagenic (Sato et al., 1986): however, the 
chlorinated humic acid showed a mutagenic response in the Ames test (Coleman et al., 1984) 
(Coleman et al. 1984& Hemming, J. et al, 1986). BPA is not mutagenic (Ike et al. 2002), and 
from our previous study Gilmour et al. ( 2012) was found that BPA is not genotoxic.  In this 
study, it is confirmed that the mixture of BPA, SMX, E2 and HA is also not mutagenic under any 
of the AOP treatments, however, UV/H2O2 treatment produced somewhat higher numbers of 
mutants in some of the mixtures.  
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Figure 4.20: The Ames result for Salmonella typhimurium TA 97 
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Figure 4.21: The Ames result for Salmonella typhimurium TA 100 
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Chapter Five 
 
Conclusions and Recommendations 
 
5.1 Conclusions 
 
 SMX showed ~ 100% removal in all the AOPs; whereas E2 and BPA showed much 
higher degradation in ozonation compared to UV processes.  
 The addition of UV with O3 produced significant increase in degradation rate for SMX; 
however, it only increased by 18% and 5% for E2 and BPA, respectively. 
 The combination of H2O2 with UV produced faster degradation rate for SMX; whereas, 
it was the lowest for E2, and the rate was reduced by 86% from that of UV/O3 for BPA . 
 Humic acid demonstrated the lowest degradation rate of all the compounds tested, and 
UV/ O3 and UV/ H2O2 demonstrated comparable rates.  
 All the mixtures of SMX after ozonation gave a higher degradation rate when they were 
combined with HA. On the other hand, E2 gave a higher rate when it was alone. While 
the effect of HA on BPA degradation was mixed.  
 There is a significant difference between the degradation of the parent compounds and 
complete mineralization indicated by low TOC removal. 
 The percentage of TOC removal was reduced when HA was added to the mixture.  
 HA and SMX are not estrogenic; however, when they were in the mixture with E2 they 
had a synergistic interaction that led to increase in estrogencity by  2.7- 4.7 times. 
 BPA  is a weak xenoestrogen that was able to create an impact upon E2 which is a strong 
estrogen by increasing the estrogencity of E2 by 2.4 times.  
 Some mixtures showed an antagonistic interaction that resulted in dropping EEQ. The 
exact mechanism for this drop in estrogencity needs to be investigated. 
 UV/ O3 is the best AOPs in this experimental conditions in terms of parent compound 
degradation, mineralization and reduction in the estrogencity, followed by ozonation. 
UV/H2O2 performed poorly in many of the cases.  
 No mutagenicity was shown by the Ames test for all pure compounds and mixtures after 
different exposure times, which means that the intermediates that produced from the 
parent compound are not mutagenic. 
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5.2 Recommendations for future study 
 
On the basis of the present study, some areas were revealed to be of significant interest for future 
research. They are listed as follows: 
 
 Further testing to include assays to monitor in-vivo effect of these micropollutants 
mutagenicity and estrogencity and environmental ecotoxicity  
 Further bioassay analysis for spiked SMX, BPA, E2 and HA into wastewater and 
drinking water samples to evaluate complex matrix effect on the toxic by-product 
formation during the degradation in AOPs. 
  
 Studying the impact of pH and other AOPs such as Fenton’s reagent, microwave and 
OH• radical scavengers. 
 
 Quantifying intermediates of 17-β estradiol, bisphenol A, sulfamethoxazole, and humic 
acid that have been formed which are more estrogenic; in order to determine the effective 
AOPs to degrade them. 
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Appendix 
Appendix 6.1: the MAT Lab code for the EEQ calculation of the YES assay.    
 
[data,text,raw]=xlsread('All_Data.xlsx','','F5:Q536'); 
%blank=xlsread('All-Data.xlsx','','F6:Q7'); 
%standsample=xlsread('All-Data.xlsx','','F3:Q5'); 
[times,text, raw]=xlsread('All_Data.xlsx','','A5:C536'); 
times=num2str(times); 
AOP_Titles=strcat('Sample:  ', raw(:,1), '; AOP: ', raw(:,3), '; Time: ',times); 
 
[ndata,mdata]=size(data); 
 
 
%examin data 
highvalues=max(data')'; 
stdev_high=std(highvalues)/mean(highvalues)*100; 
highvalue=mean(highvalues); 
%=> fix upper fitting parameter to highvalue and lower parameter to zero 
 
 
 
%create vector with dilition factor assuming first well was diluted 10 in 
%200 uL 
DF=0.05; 
for i=2:12 
    DF(i)=DF(i-1)/2; 
end 
 
c=logspace(log10(min(DF)),log10(max(DF))); 
 
 
% %Fitting all four parameters for data 
 
for g=1:ndata 
    Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,0]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve); 
 
end 
 
 
% fixing outliers 
 
    %fixing set 29 and 30 by fixing b 
for g=29:30; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
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    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,1.6]; 
    options.Upper = [10,10,10,1.601]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
end 
    %fixing set 39 by fixing b 
g=39; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,1.65]; 
    options.Upper = [10,10,10,1.651]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
 
    %fixing set 49 by fixing b 
g=49; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,2.25]; 
    options.Upper = [10,10,10,2.251]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
     
    %fixing set 331 and 340 by fixing b 
for g=331:340; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,1.2]; 
    options.Upper = [10,10,10,1.201]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
end 
 
    %fixing set 341 and 350 by fixing b 
for g=341:350; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,1.34]; 
    options.Upper = [10,10,10,1.341]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
end 
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    %fixing set 351 and 360 by fixing b 
for g=351:360; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,1.1]; 
    options.Upper = [10,10,10,1.11]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
end 
 
    %fixing set 443 and 446 by fixing b 
for g=443:446; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,2.8]; 
    options.Upper = [10,10,10,2.81]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
end 
 
  %fixing set 465 by fixing b 
g=465; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,3.6]; 
    options.Upper = [10,10,10,3.61]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
     
      %fixing set 467 by fixing b 
g=467; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
    options.Lower = [0,0,0,2.6]; 
    options.Upper = [10,10,10,2.61]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
 
    %fixing set 473 and 480 by fixing b 
for g=443:446; 
Hilleq2=fittype(@(EC50, m, a, b, x) a+(b-a)./(1+(x./EC50).^(-m))); 
    p0=[0.001,2,0.7,1.8]; 
    options = fitoptions(Hilleq2); 
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    options.Lower = [0,0,0,2.6]; 
    options.Upper = [10,10,10,2.61]; 
    options.StartPoint = p0; 
    curve = fit( DF', data(g,:)', Hilleq2, options ); 
    newcoeffcientsdata(g,:)=coeffvalues(curve);  
end 
 
 
 
% fixing irrelevent EC50 vlaues 
newcoeffcientsdata(1:10,1)=100; 
for fixer=44:2:70 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=67:2:69 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=85:1:90 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=105:1:110 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=125:1:130 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=147:1:150 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=161:1:290 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=297:1:300 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=307:1:310 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=317:1:320 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=377:1:380 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=397:1:400 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=401:1:430 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=433:1:440 
   newcoeffcientsdata(fixer,1)=100;  
end 
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for fixer=447:1:450 
   newcoeffcientsdata(fixer,1)=100;  
end 
for fixer=491:1:532 
   newcoeffcientsdata(fixer,1)=100;  
end 
 
%plotting newly fitted data 
for g=2:2:528 
   AOP=ceil(g/10); 
   figure(AOP) 
    
   fitteddatanewdata(g-1,:)= newcoeffcientsdata(g-1,3)+(newcoeffcientsdata(g-1,4)-newcoeffcientsdata(g-
1,3))./(1+(c./newcoeffcientsdata(g-1,1)).^(-newcoeffcientsdata(g-1,2))); 
   fitteddatanewdata(g,:)= newcoeffcientsdata(g,3)+(newcoeffcientsdata(g,4)-
newcoeffcientsdata(g,3))./(1+(c./newcoeffcientsdata(g,1)).^(-newcoeffcientsdata(g,2))); 
   subplot(5,1,(g-10*(AOP-1))/2) 
   semilogx(c, fitteddatanewdata(g-1,:),'r') 
   hold on 
   semilogx(c, fitteddatanewdata(g,:)) 
   semilogx(DF, data(g-1,:), 'ro') 
   semilogx(DF, data(g,:), 'x') 
   title(AOP_Titles(g-1)) 
   semilogx([newcoeffcientsdata(g-1,1), newcoeffcientsdata(g-1,1)],[newcoeffcientsdata(g-1,3), 
newcoeffcientsdata(g-1,4)], 'r', [newcoeffcientsdata(g,1), newcoeffcientsdata(g,1)],[newcoeffcientsdata(g,3), 
newcoeffcientsdata(g,4)])  
   axis([10^-5 10^-1 0 3]) 
 
end 
 
for g=530:2:532 
   AOP=ceil((g+2)/10); 
   figure(AOP) 
    
   fitteddatanewdata(g-1,:)= newcoeffcientsdata(g-1,3)+(newcoeffcientsdata(g-1,4)-newcoeffcientsdata(g-
1,3))./(1+(c./newcoeffcientsdata(g-1,1)).^(-newcoeffcientsdata(g-1,2))); 
   fitteddatanewdata(g,:)= newcoeffcientsdata(g,3)+(newcoeffcientsdata(g,4)-
newcoeffcientsdata(g,3))./(1+(c./newcoeffcientsdata(g,1)).^(-newcoeffcientsdata(g,2))); 
   subplot(5,1,(g+2-10*(AOP-1))/2) 
   semilogx(c, fitteddatanewdata(g-1,:),'r') 
   hold on 
   semilogx(c, fitteddatanewdata(g,:)) 
   semilogx(DF, data(g-1,:), 'ro') 
   semilogx(DF, data(g,:), 'x') 
   title(AOP_Titles(g-1)) 
   semilogx([newcoeffcientsdata(g-1,1), newcoeffcientsdata(g-1,1)],[newcoeffcientsdata(g-1,3), 
newcoeffcientsdata(g-1,4)], 'r', [newcoeffcientsdata(g,1), newcoeffcientsdata(g,1)],[newcoeffcientsdata(g,3), 
newcoeffcientsdata(g,4)])  
   axis([10^-5 10^-1 0 3]) 
 
end 
 
   %exporting tif files 
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   for AOP=1:ceil(g/10) +1 
     fnam=strcat('Fig_',num2str(AOP),'.tif');  
     snam='sura'; 
     s=hgexport('readstyle',snam); 
     s.Format='tiff'; 
     hgexport(AOP,fnam,s); 
   end 
   
 
EC50=newcoeffcientsdata(:,1); 
xlswrite('EC50.xlsx', EC50); 
 
 
Appendix 6.2:  
The rest of the EEQ figures for the YES assay using Mat Lab is attached in appendix 6.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
130 
 
Curriculum Vitae 
Name:  Sura Ali 
 
Post-Secondary Education and Degrees: 
Master Degree of Science in Veterinary Medicine/ Microbiology                                       1999  
University of Baghdad   
 
Bachelor of Veterinary Medicine and Surgery                                                                     1996  
University of Baghdad  
 
Awards and Scholarships 
Western Graduate Research Scholarship- WGRS. 
 
Related work experiences 
Microbiologist R&D/ Germiphene Corporation/ Canada                                   May 2014- Current 
Teaching assistant/ Western University/ Canada                                              Sep 2012- Dec 2013 
Research associate / The University of Western Ontario/ Canada                         May- Nov, 2011 
Microbiologist/ EMC Scientific Incorporated/ Canada                                    Dec 2006- Mar 2011 
University Faculty Member/ Faculty of Science-                                             Jan 2000- Aug 2006  
-The 7th of April University/ Libya 
Laboratory Technician/ Al-Canal Medical Laboratory /Iraq                            Sep 1996- Dec 2000 
 
Selected publications: 
Sarkar, S, Ali, S., Nakhla G., Rehmann, L. and M. Ray. 2014. Degradation of Estrone in Water 
and Wastewater by Various Advanced Oxidation Processes. Journal of Hazardous Materials 278, 
16–24. 
 
 
 
131 
 
Chawla, C. Sarkar, S, Ali, S., Nakhla G., Rehmann, L. and M. Ray. 2014. Anaerobic 
Digestibility of Estrogens in Wastewater Sludge: Effect of Ultrasonic Pretreatment.  Journal of 
Environmental Management 145, 307-313. 
 
Sarkar, S, Ali, S., Nakhla G., Rehmann, L. and M. Ray. 2013. Advanced Oxidation of Estrone in 
Water and Wastewater. American Institute of Chemical Engineers (AICHE) Conference, San 
Francisco, California, USA. Aug 2013. 
 
Referred Conference Proceedings: 
Ali, S., Rehmann, L., Ray, M.. 2013, Genotoxicity and estrogencity of sulfamethoxazole and 17- 
estradiol: effect of advance oxidation treatments. 63rd Canadian Chemical Engineering 
Conference, October 23, 2013, Fredericton, NB, Canada..  
 
Ali, S., Sarkar, S, Rehmann, L., Ray, M. 2013, Bioassay for Estrogencity of Micropollutants in 
Wastewater after Ultrasonication as a pre-treatment, 15th CSChE Quebec-Ontario Biotechnology 
meeting, May 30- 31, 2013, Quebec, Canada.  
 
Gilmour, C. Ali, S. Rehmann, L. Ray, M. 2012, Comparative of Genotoxicity of Bisphenol A 
degradation intermediates formed Ozonation, UV/H2O2 and photocatalytic Advance Oxidation 
Treatment, 62 nd Canadian Chemical Engineering (CSChE 2012). Conference, October 14– 17, 
2012, Vancouver, B.C., Canada.  
 
Glimour, C. Ali, S. Rehmann, L. and Ray, M. 2011, Genotoxicity of Endocrine Disrupting 
Compound Intermediates formed in Various Advanced Oxidation Processes, 61st Canadian 
Chemical Engineering (CSChE 2011) Conference, October 23–26, 2011, London, Ontario, 
Canada.  
 
Ali, S. Al Bana, A. S. and Al- Khayatt, R. M. H. 1999. Isolation and diagnosis the first two 
isolates of Equine Influenza virus from Iraq, The Seventh Vocational Scientific Conference 
November 10-12-1999. Baghdad, Iraq.  
 
 
 
132 
 
Ali, S. Al Bana, A. S. and Al- Khayatt, R. M. H. 1999, Isolation and diagnosis of human 
influenza virus by using chicken embryo fibroblast and tissue culture, The Seventh Vocational 
Scientific Conference November 10-12/1999, Baghdad, Iraq.  
 
Ali, S. Al Bana, A. S and Al- Khayatt, R. M. H. 1999, Study the Antigenic and serological 
relationship between human and equine influenza virus by using HI, SRH and CFT, The Third 
Scientific Conference of Shared Diseases. May, 16-17/2000, Baghdad, Iraq 
 
Poster Presentations: 
Ali, S., Sarkar, S, Rehmann, L. Ray, M. 2013, Bioassay for Estrogencity of Estrone in Anaerobic 
digestion: The Effect of Ultrasonication as a Pre-treatment. Research bridge, July 11, 2013, 
Sarnia.  
 
Rehmann, L., Ali, S., Schwab, K., Mehdizadeh Allaf, M., Luque, L., Schwanitz, K., Manocha, 
D., Nagendra, V., Sarchami, T. 2012, From Fuel to Pharmaceuticals: Biotransformation Process 
Development. The Western Research Showcase, March 28, 2012, London, Ontario, Canada.  
 
 
Ray, M., Ali, S.,Glimour, C., Ferguson, D., Sarkar, S., Shao, Y., AlShara, Q. 2012, Advanced 
Technologies of Environmental Remediation. The Western Research Showcase, March 28, 2012, 
London, Ontario, Canada.  
 
  
Mehdizadeh Allaf, M., Ali, S., Rehmann, L., Ray, M. 2011, Evaluation of the Potential 
Mutagenicity of BPA via the Ames Fluctuation Test. 61st Canadian Chemical Engineering 
(CSChE 2011) Conference, October 23–26, 2011, London, Ontario, Canada. 
 
